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THESIS OVERVIEW 
 
Targeting protein-protein interactions is a challenging task in drug discovery 
process. Despite the challenges, several studies have provided evidences for the 
development of small molecules modulating protein-protein interactions. In Part I, it is 
demonstrated that how a small molecule can induce the formation of an otherwise 
unstable protein-protein complex. A study of the stabilization of a FKBP12-FRB 
complex by a small molecule rapamycin is presented. The stability of the complex is 
analyzed and its interactions are characterized at the atomic level by performing free 
energy calculations and computational alanine scanning. It is shown that rapamycin 
stabilizes the complex by acting as a bridge between the two proteins; and the complex is 
stable only in the presence of rapamycin. The reported results and the good performance 
of standard molecular modeling techniques in describing the model system can be 
interesting not only in the design and development of improved molecules acting as 
FKBP12–FRB protein interaction stabilizers, but also in the somehow neglected study of 
protein-protein interactions stabilizers in general.   
In Part II, studies regarding computational modeling of the application of 
mechanical force to biomolecules is presented. This part is further divided into two 
chapters since the investigations have been performed on two biological systems. In the 
first chapter of Part II (chapter 6), it is described that how the osmolyte molecules affect 
the mechanical unfolding of a peptide. The mechanical unfolding of peptide has been 
performed by using Steered Molecular Dynamics. In this study, the effect of four 
different osmolytes on the free energy difference between the folded and the denatured 
state have been calculated. The observed trend mirrors the expected behavior of the 
studied osmolytes and unfolding pathways analysis allows an insight into the mechanism 
of action of osmolytes.  
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After the successful application of Steered molecular dynamics technique on the 
β-hairpin peptide, the same is applied on tubulin heterodimers for the in-depth study of 
the lateral and longitudinal interactions which are responsible for the stability and 
dynamics of the microtubules. In the other chapter of Part II (chapter 7), these 
interactions are studied with the help of mechanical dissociation of the tubulin 
heterodimers. These studies have allowed the identification of the critical interactions 
responsible for the binding of tubulin heterodimers laterally as well as longitudinally. 
The observations obtained could be important for the design of compounds that target 
these interactions and acts as microtubule inhibitors or stabilizers. 
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PART I 
 
 
 
 
 
 
 
 
 
 
Molecular Insights into the 
Stabilization of Protein-Protein 
Interactions with Small 
Molecule:  
The FKBP12-Rapamycin-FRB 
Case Study 
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CHAPTER 1 
PROTEIN-PROTEIN 
INTERACTIONS 
 
 
1.1  Introduction: Protein-protein Interactions 
 
The basic building block of all living organism is DNA (Deoxyribonucleic acid) 
which is transcribed into RNA (Ribonucleic acid), which in turn translated to proteins. 
The proteins are responsible for almost every task of the cellular life. The haploid human 
genome is composed of three billion base pairs and about 20,000 to 30,000 protein-
coding genes which is less than 2% of the whole genome. Protein-coding genes are the 
most widely studied and best understood components of a genome. These protein coding 
genes may encode over 500,000 proteins. Proteins are responsible for vast array of 
biological functions. It has been pointed out that approximately 80% of the proteins in a 
cell do not stand alone, but rather interact with other proteins to perform a biological 
function. The complexity of the interaction increases when the cell is in the condition of 
stress and disease (1). Cellular systems can be considered as complex networks where 
the molecules are the nodes and the associations between them are the edges of the 
network. Collectively, all types of interactions can be referred as an interactome. For 
reference, the size of the binary human interactome has been estimated to comprise about 
130,000 Protein-Protein Interactions, of which only 8% have been identified till now. So, 
there is a great need of enhancing the knowledge in this field (2).   
Chapter 1: Protein-Protein Interactions  
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Proteins mutually interact with each other for specific biological functions. 
Protein–protein Interactions (PPIs) are defined as physical interaction between two or 
more proteins that occur within a cell as well as between cells. PPIs are parts of PPI 
networks that control the flow of information both within and between biological 
processes (3). Figure 1 illustrates a case of PPI, where Interleukin-2 and alpha subunit of 
Interleukin‟s receptor interact to form a complex which in turn is responsible for 
performing a specific biological function.  
 
Figure 1: The illustration of PPI which represents the two participant proteins A and B. They 
interact to form a complex AB which is responsible for performing specific biological function. 
Here, AB represents the structure of the complex of interleukin-2 with its alpha receptor. A 
represents Interleukin-2 and B represents alpha subunit of its alpha receptor. The area marked 
with red represents the interface of the complex (protein-protein interface).    
 
PPIs are essential components of almost all cellular processes, which leads to a 
great deal of biological functions like cell proliferation, growth differentiation, 
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modulating or initiating signal transduction, gene transcription, providing cytoskeletal 
stability, promoting cellular replication or death (2). To perform a specific biological 
function, PPIs need to be at the right location and at the right time. Any disruption in the 
PPI network has been shown to result in various diseases including cancer (4). Thus, 
understanding how the proteins interact with each other has allowed us to elucidate the 
molecular basis of different diseases. This suggests the possibility of targeting PPIs for 
drug discovery, which, as we shall explain later, is more challenging than the traditional 
drug discovery, and that is why; there is a great necessity for the detailed understanding 
of the network of these interactions at the atomic level.  
 
1.2  Structural characteristics of Protein–protein 
Interfaces 
Proteins interact with each other through their surfaces, thus a great focus has 
been made to the analysis of the geometrical, structural and dynamical aspects of protein 
surfaces mediating PPIs. 
1.2.1  Types of Protein-protein Interactions 
PPIs can be classified as permanent or transient according to their binding lifetime. 
Permanent PPIs: In permanent/obligate type of PPIs, proteins form multi-subunit 
complexes and the participant proteins are permanently bound with one another. For 
example, hemoglobin and RNA polymerase form stable complex. Participant proteins of 
this group of PPIs bind more strongly and their interfaces are larger and exhibit high 
shape complementarity. They have tighter packing and very few water molecules are 
trapped between the participant proteins. These interfaces contain an over-abundance of 
non-polar amino acids, especially near the center and contact surfaces (5).  
Chapter 1: Protein-Protein Interactions  
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Transient PPIs: In transient/non-obligate type of PPIs, the interactions are temporary in 
nature, i.e. they associate and dissociate under particular physiological conditions like 
phosphorylation and conformational changes. The strength of these interactions is 
strongly dependent on the modulation by other molecules like cofactors. Transient 
interactions can be fast or slow, strong or weak. Transient PPIs does not have much 
higher percentage of non-polar amino acids (3). 
 
The main interactions that are responsible for the binding of proteins are 
hydrophobic in nature. Polar and electrostatic interactions (hydrogen bonds and salt-
bridges) also play important roles. When the proteins bind, the components of the 
complex bury part of their accessible surface area, which is inaccessible to the solvent 
due to protein-protein contact. This surface is referred as the interface. The surface area 
of the interface is usually large (approx. 1500-3000 Å
2
) (6). This surface corresponds to 
the protein portion that is excluded from solvent upon binding, and is also known as 
buried surface. The interfaces is largely made up of hydrophobic amino acids like Tyr, 
His, Trp, Phe (7). This is especially evident in stable PPIs where protein interfaces have 
a composition very similar to protein interiors (8), (9), while in transient complexes this 
feature is less evident (7), (10). Charged residues are less abundant on the interfaces 
except Arg which is found in abundance (7).  
 
1.2.2    Hot spots: The regions on the Protein-Protein interface 
responsible for binding 
 
Experimentally, it has been observed that not all the residues that are present at 
the protein-protein interface contribute equally to the binding free energy. An approach 
called, Alanine Scanning has widely been used to predict those residues at the interface 
that contribute to the binding free energy. In this approach, the residues located at the 
Chapter 1: Protein-Protein Interactions  
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protein-protein interfaces are mutated into alanine and the difference in the binding free 
energy (ΔΔG) is measured between wild type and mutated complex. In fact, only a small 
fraction of residues at the interface, around 10%, shows ΔΔG values greater than 2 
kcal/mol. (11), (12). This method will be discussed in detail in the following section. 
These small subsets of residues at the protein-protein interface that contribute to the 
binding energy are known as „hot spots‟. The interface is composed of a core and a rim. 
The residues in the core region are buried and are surrounded by the residues of the rim 
region. The core region is enriched with hydrophobic residues and the amino acid 
composition of rim region is same as that of rest of the protein (13). Keskin and 
coworkers have shown that there is a linear correlation between the numbers of hot- 
spots and the interface size (14). The residues around the hot spot regions are more 
tightly packed as compared to rest of the interface.  
 
1.2.3  Types of Atoms at the protein-protein interface 
 
Recognition sites at the interface are composed of various types of atoms: 
interface atoms, contact atoms and buried atoms (7)  
(i) Interface atoms: All those atoms that lose solvent accessible surface on the 
formation of the complex are interface atoms. Type A, B and C shown in figure 
2 are interface atoms. Not all the interface atoms make actual Van der Waal‟s 
(vdw) contact across the interface.  
(ii) Contact atoms: These atoms are the subset of the interface atoms. These atoms 
actually make vdw contact across the interface. It can be further classified to 
fully buried contact atoms and partially buried contact atoms.  
Chapter 1: Protein-Protein Interactions  
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Fully Buried contact atoms: Those atoms that are accessible in the free 
components but have zero accessible surface area in the complex. (Type B 
shown in Figure 2) 
Partially Buried contact atoms: Those atoms that are partially accessible to 
solvent and makes vdw contact across the interface. (Type C shown in Figure 2) 
   
 
Figure 2: Figure represents the class of interface atoms in a protein-protein complex. One protein 
partner is shown at the top and the other is shown at the bottom. For clarity, atoms are specified 
for the bottom one only. Type B represents completely buried atoms. Type A and C retain partial 
solvent accessibility. Type B and C are contact atoms that make vdw contacts with the top protein 
partner. Type A represents the peripheral interface atoms. The sphere with W represents water 
molecule. The figure is reprinted from "The atomic structure of protein-protein recognition sites," 
L. Jo Conte et al, 1999, J. Mol. Biol.,285, p. 2182 (7)  
 
One-half of the total interface atoms are contact atoms and one-third are buried 
atoms. The remaining atoms belong to the peripheral interface atoms of type A. The 
number of interface atoms scales linearly with the interface area (7). Bogan and Thorn, 
through experimental alanine scanning mutagenesis studies have shown that the hot 
spots are not homogenously distributed over the protein-protein interface, rather they are 
present in form of clusters. They have found that the hot spots are clustered in the center 
of the interface rather than at the rim (15). Hot spots have a tendency to couple across the 
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binding interfaces. Figure 3 illustrates the hot spot regions on the protein-protein 
interface.              
 
Figure 3: The figure represents the ribbon diagram of a protein-protein complex showing hot 
spots at the interface. Here, structure of the complex of interleukin-2 (blue) with its alpha receptor 
(yellow) is shown and the hot spots are represented in red.  
 
1.3  Protein-Protein Interactions in drug design  
 
1.3.1  PPIs as Drug Targets: 
 
PPIs are an attractive emerging class of drug targets. Disruption or deregulation 
of the PPIs leads to a number of diseases like cancer and neurodegenerative diseases 
(16). This may happen through the loss of essential interaction, or through the formation 
of the protein complexes at an inappropriate time or location. Consequently, so many 
researches are going on, in order to study, how the proteins communicate with each other 
at the molecular basis. These researches are focused on the PPIs modulation (inhibition 
or stabilization) to develop novel therapeutic approaches especially in the anticancer 
field. There is a need to identify and assess useful and novel approaches for the design 
Chapter 1: Protein-Protein Interactions  
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and identification of “small molecule PPI modulators”. These small molecule PPI 
modulators are a natural or synthetic product having a molecular weight of 500-900 Da, 
which has target selectivity and good binding affinity. They regulate PPI either through 
inhibition or through stabilization (17).  
PPIs can have different extent of druggability. Druggability of PPI depends on 
the structure and physiochemical characteristics of the interface. London et al (18) 
demonstrated that the druggable PPIs are dominated by „hot segments‟. „Hot segments‟ 
is an extension to the concept of hot spots. It can be explained as a continuous peptide 
stretch within a protein that contributes most to the binding (19).  
It has been estimated that about 10% of the human genome is involved in some 
type of disease state, resulting in corresponding 3000 potential drug targets (20). Sugaya 
et al has developed a SVM (support vector machine) based method for the prediction of 
druggable PPIs (21)  
 
1.3.2  PPIs: Challenges  
 
PPIs are quite different from protein-ligand or enzyme-inhibitor interactions and 
designing small molecule PPI modulators is a challenging task. These challenges include 
the lack of binding pockets at the protein-protein interface. Interface is usually large 
(approx. 1500-3000 Å
2
), flat and featureless. So, it is more challenging to obtain 
modulators for flat interfaces than for interfaces with well-defined pockets (6). 
Moreover, unlike enzymes, protein-protein interfaces are more diverse and the binding 
sites do not appear to be preserved. So, each protein interface is unique. (13), (22). 
Although, protein interfaces are larger in size, but the cluster of hot spots are distributed 
over the entire interface, making it possible to design low molecular weight compounds 
targeting hot-spot clusters. Small molecule discovered till now that inhibits/stabilizes 
PPI, have shown that PPIs can act as drug targets. For instance, proteins Bcl-2 and Bcl 
Chapter 1: Protein-Protein Interactions  
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XL (regulators of apoptotic cell death), and HDM2 (an oncoprotein with both p53- 
dependent and independent functions) are examples of signaling proteins where PPIs 
have been targeted and small molecules have entered clinical trials (23), (24).      
It has been established that for the modulation of the PPI, a molecule is not 
required to bind with the large area of the protein‟s interface. In fact, it interacts with a 
small subset of amino acids.  
1.3.3  Modulation of PPI 
 
In principle, a protein-protein interaction can be exploited as a drug target either 
by reducing its strength, thus impairing protein complex formation, or by increasing its 
strength to stabilize the complex. It depends on the nature of the process mediated by the 
PPI and on the therapeutic aim whichever is the suitable strategy to be adopted in each 
case. So far, most efforts have been devoted to the design and development of PPIs 
inhibitors (25), (26) but recently, also PPIs stabilizing agents have gained an increasing 
attention (2).  
 
PPI Inhibition: PPI inhibition is a process where a small molecule competes with the 
original protein partner of the PPI resulting in the disruption of the function. PPI 
inhibitors can target two sites: hot spots or allosteric sites. Figure 4a represents hot-spots 
approach to PPI inhibition. Figure 4b represents allosteric regulation mechanism of PPI 
inhibition. In allosteric mechanism, the inhibitor molecule binds at the distant site from 
the PP interface and induces structural modifications in the protein, resulting in inability 
of the binding of two protein partners (22), (27). Several studies have been performed on 
the direct and allosteric mechanism of PPI inhibition. For instance, P-arylthio 
cinnamides inhibits allosterically the interaction between Leukocyte function-associated 
antigen -1 (LFA-1) and intracellular adhesion molecule-1 (ICAM-1) (28). Drugs like 
Vinca alkaloids and colchicine directly inhibits microtubule polymerization by targeting 
tubulin-tubulin interaction (29). Generally, such small molecule inhibitors can cover an 
average of approximately 300-1000 Å
2
 of protein-protein interaction surface. As the 
Chapter 1: Protein-Protein Interactions  
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surface area of the hot spot is approximately 600 Å
2
, so these molecules can represent 
good starting points for developing better therapeutic agents (17). 
 
1.3.4  Strategies to identify small molecule PPI modulators 
 
There are three main classes of PPI modulators which can be identified: humanized 
monoclonal antibodies, small molecules and; peptides and peptidomimetics derived from 
PP interfaces. Antibodies are attractive modulators because of their high target 
selectivity. But they have drawbacks like poor cell permeability and they are not orally 
bioavailable. On the other hand, peptides derived from PP interface are better modulators 
as they are considered as the starting point for the development of small molecule PPI-
modulators. However, they suffer from drawbacks like poor metabolic stability and low 
bioavailability. Therefore, there is a need of new modified types of peptides with 
improved stability, metabolic and pharmacokinetic properties (17). The identification 
approaches of the small molecule PPI modulators can be classified in the following 
categories: 
 
1. Peptide and peptidomimetic approaches. 
2. High throughput screening of chemical libraries and natural products. 
3. Computational approaches based on X-Ray crystallography and NMR data. 
 
The above approaches will be discussed in short. In peptide and peptidomimetic 
approaches, peptides with structures based on amino acid sequence at the PP interface is 
selected which acts as a lead for the development of novel and improved PPI modulators 
(30). High Throughput Screening is a selective approach for the discovery of lead PPI 
modulators (27), (31), (32), (33). To make HTS successful, two key things are important, 
first to maximize the chance of identifying suitable binding molecule (both in terms of 
selectivity and affinity) and the second key thing is the choice of assay (17). In the 
present time, computational approaches are promising strategy to identify and design 
Chapter 1: Protein-Protein Interactions  
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small- molecule PPI modulators (34), (35), (36), (37). Computational approaches assist 
various steps in drug discovery process since performing identification only through 
experimental methods is very time consuming and expensive. So, in the last ten years, 
there has been an increasing effort to develop computational strategies to screen PP 
interfaces (38), (12), (39). Several studies have documented the use of in-silico 
approaches with medicinal chemistry approaches in the discovery of PPI modulators  
(40), (41), (42), (38). 
 
1.4  PPI stabilization 
 
In this study, we focus on the stabilization of the PPI, where a small molecule 
strengthens the naturally occurring PPIs by binding to both of the protein partners. 
Stabilization can be accomplished either with an allosteric or a direct mechanism. In 
allosteric mechanism of PPI stabilization, stabilizer can bind to a single protein partner, 
increasing the mutual binding affinity of the protein partners by inducing conformational 
modifications. A typical example of allosteric mechanism of PPI stabilization is shown 
by paclitaxel. Paclitaxel is a small molecule modulator which binds to a hydrophobic 
pocket of the β subunit of polymerized tubulin and stabilizes polymerized microtubule 
structure (43), (44). In direct stabilization of PPI, the stabilizer binds to both of the 
protein partners, exerting a bridge like function which also increases the mutual binding 
affinity (2). Direct mechanism of PPI stabilization can be of two types. In first type, the 
stabilizing molecule first binds to one of the protein partners, thereby modifying the 
interaction surface for the second protein partner and stabilizes the complex. The effect 
of stabilizer is so strong that the complex is not stable in the absence of these stabilizers. 
In the second type of direct PPI stabilization, the stabilizer molecule directly binds to the 
rim of an already established PP interface and increases the binding affinity of the 
protein partners (2). Figure 4c shows the mechanism of direct stabilization.  
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Figure 4: (a) Hot spot approach to PPI inhibition. (b) Allosteric approach to PPI inhibition. (c) 
PPI stabilization by direct mechanism. The two protein partners are represented in green and blue. 
Hot spot is represented in yellow. Reprinted from “Targeting protein-protein interactions for 
therapeutic intervention: a challenge for the future” by G. Zinzalla and D. E. Thurston, 2009. 
Future Med. Chem., 1, p.68. (17) 
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Figure 5: The structure of the ternary complex of FKBP12-rapamycin-FRB is shown representing 
PPI-stabilization. FKBP12 partner of the complex is represented in cyan whereas FRB partner in 
green. Rapamycin molecule is denoted in red. Image is rendered with Visual Molecular Dynamics 
(VMD) (45) 
 
In this work, we have studied a typical case of first type of direct mechanism of 
PPI stabilization, the complex between FK506-binding protein (FKBP12) and FKBP12-
rapamycin-binding domain of FRAP (FRB) with the small molecule stabilizer rapamycin 
(Figure 5). FRAP is FKBP-Rapamycin Associated Protein (46).  
 
The approach of stabilization of PPI offers a valuable alternative for the 
discovery of novel bio-active drug-like molecules. Nature has provided us a number of 
compounds that acts as PPI stabilizers and they are good starting point in the drug 
discovery process. PPI stabilizers have several advantages. As they bind in a non-
competitive way, their affinity does not need to be in low nanomolar range to trigger a 
strong physiological effect. Moreover, on the contrary to enzymes- inhibitors which are 
less specific because of strong homologies within enzyme families, PPI stabilizers are 
more specific because the PP interface of the complexes are more distinct (2). Despite of 
these advantageous features, few instances of PPI stabilizers resulting from target-
oriented small molecule discovery have been reported yet. Nevertheless, the scientific 
community is making a great effort to pursue in this way towards drug discovery.   
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CHAPTER 2 
Computational Methods I 
 
2.1  Molecular dynamics: An overview 
 
Molecular Dynamics (MD) is a computational method which describes 
equilibrium and biological properties of a biological system. MD helps to gain insight 
into processes taking place at atomic and molecular level, which is quite difficult to have 
purely from experiments because of lack of sufficient resolution. i.e., with MD, we can 
keep track of the behavior of each atom of a system. MD simulations provide 
information about the possible conformations, thermodynamic properties and dynamic 
behavior of a molecule.  
In short, MD involves the solving of classical equations of motion for a group of atoms 
or molecules. For numerically solving those equations, MD requires three ingredients: I) 
A law which describes the mutual interaction between the atoms in a system from which 
potential energy and the forces on the atoms can be calculated given the position of 
atoms. II) An algorithm to integrate numerically the equations of motion for the atoms in 
the system. III) The integration scheme needs to be provided with initial conditions like 
initial positions and velocities of all atoms in the system to finally solve the equations. 
Apart from the above approximations, two more approximations are required. First, 
atoms should be considered as classical entities and obey Newton‟s equations of motion. 
Second, the model used for describing the interaction between the atoms of the system.  
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In MD, one explores the macroscopic properties (e.g. Pressure, energy, enthalpy) 
of the system through microscopic simulations (microscopic properties include atomic 
positions and velocities). For example, to calculate the change in binding free energy of a 
particular drug or to study the mechanism of conformational change of a molecule. The 
connection between microscopic simulations and macroscopic properties is made by 
statistical mechanics. In statistical mechanics, averages related to experiments are 
defined in terms of ensemble averages
1
, so as to have good agreement with the 
experiments. With MD simulations, one can calculate time average of any observable of 
interest (expressed as a function of momentum p and position r) by integration. Since, 
MD performs by the time average of the observables and experimental observables are 
assumed to be ensemble averages, so to resolve this, a fundamental axiom of statistical 
mechanics is used in MD. This axiom states that statistical ensemble averages are equal 
to time averages of the system, and is known as Ergodic hypothesis (47).  
 
Ensemble average = time average 
〈 〉         〈 〉     
While performing MD, a system is allowed to evolve in time for enough duration 
so that the system passes through a large number of conformational states. Therefore, the 
aim of MD is to generate enough representative conformations such that the ergodic 
hypothesis is satisfied. 
MD simulations calculate future positions and velocities of the atoms of a system, based 
on their current position and velocities (48), (49). MD is based on classical mechanics, 
i.e. on Newton‟s second law of motion. From the knowledge of the force on each atom, it 
                                                          
1 Ensemble average is average taken over a large number of replicas of the system 
considered simultaneously. 
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is possible to determine the acceleration of each atom in the system, as the mass of the 
atoms is known. The equations of motions are then integrated to generate a trajectory 
that describes the positions, velocities and accelerations of the atoms with respect to the 
time. From this trajectory, one can determine the average values of properties. MD is a 
deterministic method; i.e. once the position and velocities of each atom are known, the 
state of the system can be predicted anytime in the future.  
Newton‟s equation of motion: 
        
Where,    is the force exerted on the particle i. 
    is the mass of the particle i.   
    is the acceleration of the particle i. 
 The force can be expressed as the gradient of potential energy: 
    
  
   
 
Where, V is the potential energy function. 
Combing the above two equations: 
 
  
   
      
 
  
   
   
    
   
 
Thus, potential energy of the system can be related to the change in position of atoms 
with respect to the time. 
Kinetic energy of the system is defined in terms of velocities: 
  
 
 
∑    
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The total energy of the system is the sum of kinetic and potential energies. This is known 
as Hamiltonian and is expressed as follows: 
 (   )   ( )   ( ) 
Where, r is a set of Cartesian coordinates and p is the momenta of the atoms (50).  
Let us consider a simple case study where acceleration is constant.  
         
  
  
    
   
   
 
  
Since acceleration can be expressed as  
  
  
 , we get the velocity after integration. 
        
And, since velocity can be expressed as   
  
  
  , we get the position after integration. 
        
By combining the above expressions of velocity (v) and position (r), we get the 
following expression which gives the value of r at time t as a function of acceleration a, 
initial velocity    and initial position    
       
      
Acceleration can be expressed as a derivative of potential energy with respect to 
position: 
   
 
 
  
  
 
The equations of motion are deterministic in nature, i.e., if the initial positions and 
velocities are known, then position and velocities at time t can be calculated.  Therefore, 
for the calculation of the trajectory, the values which are needed are as follows: 
Chapter 2: Computational Methods I  
_______________________________________________________________________ 
 
_______________________________________________________________________ 
22 
 
a) Initial positions of the atoms: Through experimental structures predicted by X-
ray crystallography or NMR spectroscopy, initial position of atoms can be 
obtained.      
b) Initial distribution of the velocities: The initial velocities should obey the 
required temperature and corrected so there is no overall momentum (P), by 
setting the center of mass to zero. This prevents the system from drifting in 
space.  
  ∑      
 
   
 
Usually, the velocities    at a given temperature T, are chosen randomly by a 
Maxwell-Boltzmann distribution or Gaussian distribution. It gives the 
probability that an atom i has a velocity    in the direction X at temperature T. 
  (   )  (
  
     
)
 
 
    * 
 
 
     
 
   
+ 
 
Where,    is the velocity of atom i in direction X. 
  is the Boltzmann constant. 
c) The acceleration: It is determined by the gradient of potential energy with 
respect to the position. 
Temperature T can be calculated using velocities as follows: 
  
 
(  )
∑
|  |
   
 
   
 
Where,    is the momentum of the N is the atom i and N is the total number of atoms in 
the system. 
The potential energy is the function of all the atoms‟ atomic positions (3N). Because of 
the complex nature of the function, they must be solved numerically using various 
numerical integration methods. Several numerical algorithms have been developed; for 
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e.g. Verlet algorithm, Leap-frog algorithm and Velocity Verlet algorithm. The studies 
have been performed with Amber package based on leap-frog algorithm for numerical 
integration which is discussed below.  
Leap-frog Algorithm 
This algorithm first calculates the velocity at time (  
 
 
  ) by the following expression 
 (  
 
 
  )   (  
 
 
  )   ( )   
The velocity at time (  
 
 
  ) is used to calculate the position r at time (    ), which 
is as follows: 
 (    )   ( )   (  
 
 
  )    
In the first time step   , the velocities progresses from time     to (  
 
 
  ). In doing 
so, they “leap” over the position at time        the positions leap over the velocities. The 
expression for the calculation of velocity at time t is: 
 ( )  
 
 
[ (  
 
 
  )   (  
 
 
  )] 
 The acceleration is then determined and the cycle is renewed. Thus the velocities 
advances from (  
 
 
  ) to (  
 
 
  ) progressively and the resulting set of positions 
and velocities is the MD trajectory. 
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Figure 6: An illustration showing the principle of leap frog mechanism. Adapted from “Leap frog 
Integrator”, Computational Physics by S. McMillan (51) 
 
Force Fields 
The basic idea behind MD simulations is the representation of the energy of the molecule 
as a function of its atomic coordinates. The conformations of the molecule are stable at 
low energy regions of the potential energy function, and the forces on the individual 
atoms are related to the gradient of this potential energy function. So, such functions are 
commonly known as “force fields” (52). 
Although, the electronic structure calculations by means of quantum mechanics are 
highly accurate, it is not yet feasible to calculate energy surfaces for macromolecules by 
this method. So, most practical simulations use a set of simple classical functions to 
represent the energy, adjusting several parameters and optimizing them to be in 
agreement with experimental data (X-Ray and electron diffraction, NMR and IR 
spectroscopy) and with quantum mechanical calculations on smaller molecules. Thus in 
short, force field is a collection of simplified potential energy functions and all the 
related parameters to describe the interaction between atoms. Despite of its classical 
nature, force-fields can mimic the behavior of a system at atomic level with high 
accuracy in a fraction of time. Commonly used force fields are AMBER (53), 
CHARMM (54), GROMOS (55) and OPLS (56). Force fields must be chosen carefully 
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according to the nature of the system being simulated. In this study, we have used 
AMBER force field since this force field is appropriate for protein-protein and protein-
ligand interaction studies.   
Molecular mechanics assumes additivity of the energies: 
 ( )                       ⏟    
            
           ⏟  
                
      
 
The potential energy expression for the AMBER force field is as follows: 
 ( )   ∑   (    )
 
     
 ∑   (    )
 
      
 ∑   [   (    )   ]
         
 ∑ ∑    [(
   
   
)
  
 (
   
   
)
 
]  ∑∑
    
      
             
 
Where, the first three summation terms are over bonds, angles and dihedrals. The fourth 
summation term describes the van der Waal‟s (Leonard-Jones 6-12 potential) and the 
final term represents the electrostatic potential. 
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2.2  Free energy calculations 
 
The energetics provides the most important information about the relationship 
between the structure, function and stability of the biomolecules. Over the past decade, 
several computational approaches have been developed for the calculation of binding 
free energy, each with individual trade-offs between computational cost and accuracy. 
While choosing an approach for free energy calculations, two key points should be 
considered, accuracy and the computational cost of the method in reference to the 
available resources.  
Most fast methods for prediction of binding free energies are the empirical or 
knowledge-based approaches, which are based on simple energy functions (57), (58). 
The main disadvantage of the above mentioned approach is the lack of the 
conformational sampling which makes these methods faster but at the cost of accuracy. 
On the other hand, the most time-consuming and accurate methods are based on 
molecular force fields and they use Molecular Dynamics (MD) and Monte Carlo (MC) 
simulations to generate ensemble averages. Free energy perturbation (59) and 
thermodynamic integration (60) are such methods which gives the accurate estimates but 
are computationally time consuming, thus, difficult to estimate binding free energies for 
large protein complexes. Another approach that relies on MD or MC simulation is Linear 
Interaction Energy approach (61). Since the above mentioned methods are 
computationally expensive, so more computationally affordable yet reliable methods 
have been developed to tackle this difficult task. These methods, referred to as MM–
PBSA (Molecular Mechanics–Poisson–Boltzmann Surface Area) (62) or MM–GBSA 
(Molecular Mechanics–Generalized-Born Surface Area) (63), combine the molecular 
mechanical energies in gas phase, the Poisson–Boltzmann or the Generalized Born 
approach to evaluate solvation energy, and an empirical function to take into account the 
contribution of protein surface exposure to solvent. They perform a posteriori evaluation 
Chapter 2: Computational Methods I  
_______________________________________________________________________ 
 
_______________________________________________________________________ 
27 
 
of binding free energy on snapshots extracted from a molecular dynamics trajectory to 
evaluate the total binding free energy between two proteins forming a complex.  
 
2.2.1  MM/GBSA approach 
 
In this study, we have employed MM/GBSA approach for the calculation of 
binding free energy. MM/GBSA approach is combined Molecular Mechanics/ 
Generalized Born Surface Area to calculate the free energy of binding (64). This is faster 
method which is based on the force fields and computes free energy of binding from the 
difference between the two states (unbound and bound state) in solution. MM/GBSA 
method is very appropriate in case of protein-ligands, protein-protein and protein-peptide 
complexes. The advent of sophisticated computing-clusters and automated protein/ligand 
preparation routine makes the calculation of binding free energies by MM/GBSA model 
feasible. The net free energy change is treated as a sum of individual energy components, 
each with a physical basis. This approach uses a thermodynamic cycle (Figure 7) to 
calculate the binding free energy. 
 
Figure 7: The thermodynamic cycle to calculate the binding free energy of the complex in 
solution (ΔGAB,sol) The binding energy is decomposed into binding free energy in vacuum 
(ΔGAB,gas) and solvation free energies of the reacting species. 
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The solvation contribution of a species X can be expressed as: 
    
      ( )
→           
ΔGsolv(X) is the free energy of solvation of X. where X=A,B in this case. 
      ( )   ( )     ( )    
 ( )    is free energy of X in solvent.  ( )    is free energy of X in vacuum. 
Therefore, the free energy of X in solvent can be written as: 
 ( )          ( )   ( )    
The binding energy of the complex AB is : 
          (  )    [ ( )     ( )   ] 
          (  )     ( )     ( )    
The above equation can be written as: 
         [      (  )   (  )   ]  [      ( )   ( )   ]  [      ( )   ( )   ] 
                            (  )   (  )          ( )   ( )          ( )   ( )    
                 (  )        ( )        ( )  [ (  )    ( ( )     ( )   )] 
                           (  )        ( )        ( )          
 
                                 (  )        ( )        ( )⏟         
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The above equation is the decomposition of          into vacuum term         and a 
solvation term         according to the thermodynamic cycle of Figure 7. This equation 
is the basic equation which calculates the binding free energy on the basis of type of 
solvent model used.  
                         
Dealing with the snapshots extracted from a MD trajectory, the equation can be written 
as: 
         ⟨    ⟩              
Where, ⟨    ⟩ is the average molecular mechanics (MM) energy calculated during MD 
simulation. 
    is the entropic term. T is the absolute temperature (in Kelvin). 
 
Molecular mechanics energy contribution 
The molecular mechanics energy      is expressed as the sum of the intermolecular 
(       ) and intramolecular (       ) energies. 
                     
The intramolecular energy is composed of the energies related to bonds, angles and 
dihedrals. The intermolecular energy has two components electrostatic and van der 
Waal‟s component. 
                                               
     is the molecular mechanics energy which is calculated during MD/MC simulation.  
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Entropic contribution 
    is the entropic term which is challenging to compute. It can thus be approximated to 
     , i.e. the contribution due to the internal vibrations, whose calculation is usually 
time-consuming and can be affected by large statistical uncertainty, so it can be 
performed only on a part of a protein complex (65). Some of the researchers advocates 
its usage (66), while some believes to neglect it because it could be a reason of major 
source of error (67).  
Entropy is calculated as a combination of change in translational (    ), rotational 
(     ) and vibrational (     ) entropies, related with corresponding degrees of freedom. 
Usually, in literatures, the term „configurational entropy‟ (      ) is used.    
                        
In the case of small molecules binding to the large receptors, the first two terms (     
     ) might prevail on      . But in case of protein-protein complex, (          ) is 
generally neglected and the change in vibrational entropy (     ) is more relevant.       
is usually estimated by using Normal mode analysis of MD trajectories. 
 
Solvation contribution 
In MM/GBSA approach, the solvation term         is computed as: 
                  
Where,      refers to the electrostatic component of the solvation while      refers to 
the non-electrostatic component of the solvation, called as cavitation energy that 
corresponds to the energy needed to create the cavity occupied by the solute in the 
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solvent (68). The solvation term is evaluated „a posteriori‟ using “implicit solvent”2 
calculations. Here, it should be noted that for MD simulations, “explicit solvent”3 model 
is usually used while it have been changed to implicit solvent model for free energy 
calculations by MM/GBSA method. Thus, the solvent model and therefore the 
Hamiltonian are different in simulation and free energy calculation steps (69). 
 
Electrostatic component of the solvation term 
The first term ΔGGB can be calculated using the modified Generalized Born (GB) model 
developed by Onufriev et al (70). 
The electrostatic component of the solvation energy is related with the creation of a 
charge qi in a spherical cavity of radius ai in a solvent having dielectric constant ε. For N 
charges located at rij distance, the defining equation employed for electrostatic 
contribution to the solvation free energy with MM/GBSA model would be as follows: 
       
 
   
(  
 
 
) ∑
    
 (        )
 
    (   )
 
where,   (       )   √   
     
     
       √     
     
   
 
(    )
  
                                                          
2
 Implicit solvent is representation of the solvent as continuum medium with the dielectric 
properties. Using implicit water model is computationally affordable. Free energy by MM/GBSA 
or MM/PBSA approaches can only be estimated by using implicit continuum models (223). 
3
 Explicit solvent is where a biological molecule is surrounded by a large number of solvent 
molecules. This representation is physiologically more realistic but is computationally expensive 
because of the necessity of periodic boundary conditions (224).  
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Non-electrostatic component of the solvation term 
The second non-electrostatic term is computed as a function of solvent accessible surface 
area (71) which is as follows: 
            
where, A is the total solvent accessible surface area. γ and b are constants. 
Combining the different contributions, total free energy of binding can be expressed as: 
          ⟨    ⟩                 
 
2.3  Computational Alanine Scanning 
 
Computational alanine scanning (CAS) is a computational technique for the 
prediction of residues which are energetically important for binding of the protein 
partners in a protein-protein complex. CAS is analogous to experimental alanine 
mutagenesis. On the protein-protein interface, there are few residues that are 
energetically important; these are called “Hot Spots” by Clackson and Wells (72) in 
their work on the binding of human growth hormone to its receptor, where only a small 
fraction of interfacial residues contributes to the binding free energy. And this is the 
general property of the most protein-protein complexes (15), (73). CAS technique has 
been first used by P. Kollman to study PPIs (74). They have reported an extension to the 
MM/GBSA free energy calculation approach used by Srinivasan et al (75).  
 
The calculation is performed by evaluating the binding free energy between the 
protein subunits making up the complex (    ) and the binding energy upon mutation 
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of each interfacial generic amino acid X into alanine (      ), so, for each residue X, a 
    value can be obtained as 
                 
 
Mutating all interfacial amino acid and the calculation of      in the above 
mentioned way yields a map predicting which amino acids are important for PPI and 
which are not. These amino acids tend to be grouped into small clusters on the interface 
and they are classified on the basis of difference in binding free energy between the wild 
type and mutant type as hot spots (    > 4 kcal mol-1), warm spots (2 kcal mol-1 <     
< 4 kcal mol
-1
) and cold spots or null spots (    < 2 kcal mol-1) (76). These hot spots 
are correlated with conserved residues at specific locations. The fundamental principle of 
CAS is based on experimental alanine mutagenesis. Despite of advances in molecular 
biology, experimental alanine mutagenesis is more time consuming, difficult and 
expensive for performing high throughput screening of PP interfaces. Thus, CAS plays 
important role in predicting hot spots in modeled or experimentally determined PP 
complexes. CAS along with structural and thermodynamic studies has enabled the 
discovery of important protein-protein interactions. Figure 8 represents the flowchart for 
the calculation of difference in free energy of binding (   ) by CAS approach.  
There are some assumptions that were made in the calculation of     by CAS 
approach which are as follows: 
1. The terms in the energy function used for the calculation of     (refer to 
section 2.2.1) are pairwise additive. This assumption is necessary for the fast 
computational evaluation of    .  
2. Next assumption is that in CAS approach, cofactors, metal ions and water 
molecules participating in hydrogen bonding at the protein interface are not 
taken into account.  
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3. Another assumption is that the symmetry in a protein-protein complex is not 
taken into account. During CAS, only one residue at a time is mutated to alanine. 
This point is valid for the protein homodimer complexes. According to CAS, one 
residue is mutated at a position in interface of a partner, and the corresponding 
residue on the other partner of the dimer is considered as wild type (77).  
4. Proline residue is not mutated to alanine and thus not considered for CAS. This 
is because its backbone conformation is different from that of alanine and the 
mutation would lead to significant conformational changes (78). While the 
mutation of other residues to alanine causes only local changes and the overall 
conformation of the complex is preserved.  
 
 
 
Figure 8: Flowchart illustrating the procedure of Computational Alanine Scanning approach 
Chapter 3- Ternary Complex: FKBP12-Rapamycin-FRB 
_______________________________________________________________________ 
 
_______________________________________________________________________ 
35 
 
CHAPTER 3 
TERNARY COMPLEX:  
FKBP12-RAPAMYCIN-FRB 
 
Abstract 
Modulating Protein-Protein Interactions is a viable therapeutic strategy to fight many 
different diseases. Several studies have been performed and provided evidence for the 
development of small molecules that modulate PPIs which has opened new opportunities 
in the field of drug discovery. In principle, PPI can be exploited as a drug target either by 
inhibiting or stabilizing the complex. Until now, most research has been dedicated to the 
design and development of PPIs inhibitors, but in recent times, several researches are 
also going on PPIs stabilizing agents. In this study, we have analyzed a typical case of 
protein-protein interaction stabilization: the complex between FKBP12 and FRB with 
rapamycin. We have analyzed the stability of the complex and characterized its 
interactions at the atomic level by performing free energy calculations and computational 
alanine scanning. It is shown that rapamycin stabilizes the complex by acting as a bridge 
between the two proteins forming the biologically active ternary complex. The main 
objective of this study is to characterize the interaction network responsible for the 
binding of rapamycin with FKBP12 and FRB and to get deeper understanding of 
rapamycin stabilization of the above mentioned complex.  
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Figure 9: The structure of the ternary complex of FKBP12–rapamycin–FRB is shown (upper 
panel) along with the chemical structure of rapamycin (lower panel). FKBP12 partner of the 
complex is represented in cyan whereas FRB partner in green. Rapamycin molecule is denoted in 
red. 
 
3.1 Biological background 
 
The biologically active ternary complex is composed of two proteins FKBP12 
and FRB and a small molecule rapamycin. FKBP12 is FK506-binding protein. FRB is 
FKBP12-Rapamycin-binding domain of FRAP. FRAP is FKBP Rapamycin associated 
protein. Figure 9 represents the structure of the complex. 
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Rapamycin is an antifungal agent produced by Streptomyces 
hygroscopicus which was isolated from Easter Island soil sample (79). This compound is 
a white crystalline solid which is insoluble in aqueous solutions but soluble in organic 
solvents (80), (81). It is a 31-membered lipophilic macrolide compound. Studies have 
shown that rapamycin has antitumor and immunosuppressive activity (82), (83). It shows 
antifungal activity especially against candida albicans and other filamentous fungi (84). 
Rapamycin has received more focused consideration as an immunosuppressant. Thus, it 
is now a FDA-approved drug and is used clinically as an immunosuppressant for organ 
transplant patients (85). Several experiments have been performed to demonstrate the 
anti-proliferative action of Rapamycin (86), (87), (88). All these activities have been 
studied and it has been observed that they share a common mechanism (89). Rapamycin 
binds to specific family of immunophilins (cytosolic binding proteins), known as FK506 
binding proteins (FKBPs). The most relevant protein of this family for the 
immunosuppressive effects of rapamycin is FKBP12. FKBP12 is a 12 kDa protein and 
functions as cis/trans peptidylpropyl isomerases that catalyzes the cis to trans 
isomerization of Xaa-proline peptide bonds in short synthetic peptides (90), (91), (92). 
Rapamycin binds to FKBP12 and inhibits its isomerase activity, but this drug–
immunophilin complex is insufficient to mediate immunosuppressive effect of 
rapamycin. Rapamycin becomes biologically active only when FKBP12–rapamycin 
complex binds with a small 11 kDa hydrophobic binding domain (FRB domain) present 
on the 289 kDa protein FRAP. This FRB domain is the specific intracellular target of 
FKBP12–rapamycin complex (93). FRAP is also referred by terms like mTOR 
(mammalian target of Rapamycin), RAFT1 (Rapamycin FKBP12 target) and RAPT1 
(Rapamycin target) (94), (95), (96). The inhibition of this protein blocks signal 
transduction pathways preventing cell cycle progression from G1 to S phase in various 
cell types, allowing rapamycin to exploit its action (89). 
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Figure 10: The signal transduction pathway showing the involvement of Rapamycin. Rapamycin 
binds to immunophilin FKBP12. The Rapamycin-FKBP12 complex binds to FRAP (represented 
here as mTOR). The ternary complex inhibits the phosphorylation and activation of downstream 
translational regulators 4E-BP1/ PHAS-1 and p70
s6k
. These in turn, decrease the translation of 
mRNA of specific proteins essential for G1 to S phase progression. Rapamycin is represented as 
RAP. Adapted from “The molecular target of rapamycin (mTOR) as a therapeutic target against 
cancer” by  M.M. Mita et al, 2003, Cancer Biology & Therapy, 2, p. S171  (97) 
 
3.1.1  Mechanism of action of Rapamycin 
 
Rapamycin interferes with the elements of the signal transduction pathways, 
especially FRAP (mTOR) pathway resulting in the cell cycle progression arrest from G1 
to S-phase. As previously mentioned, rapamycin first binds to FKBP12 and the resultant 
complex FKBP12-Rapamycin inhibits kinase activity of FRAP. This in turn blocks the 
activity of two downstream signaling elements p70
s6k
 (40s ribosomal protein s6 kinase) 
and 4E-BP1/PHAS-1 [Eukaryotic initiation factor 4E binding protein-1(4E-BP1), also 
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known as PHAS-1 (Phosphorylated heat and acid stable protein-1)]. These signaling 
elements will be discussed later in this section. The inhibition of these signaling elements 
results in the inhibition of the synthesis of proteins important for cell-cycle proliferation. 
Thus, rapamycin acts as an anti-tumor agent. Figure 10 represents the mechanism of 
action of rapamycin in FRAP (mTOR) pathway.  
 
Upstream of FRAP 
 
FRAP belongs to PIKK (phosphoinositide 3-kinase related kinase) family of 
protein kinases which is involved in many regulatory cellular functions related to cell 
cycle progression, DNA damage and repair; and DNA recombination. PIKK family 
members possess a common carboxy-terminal catalytic domain that bears sequence 
homology to lipid kinase domains of PI3K (phosphatidylinositol 3-kinase). FRAP 
contains three domains, namely: FRB domain, catalytic domain and heat domain. FRB 
domain is evolutionary conserved.  
 
Although, the precise mechanism of upstream pathway of FRAP is not 
completely understood, some researches have shown that PI3K/ protein kinase 
B(PI3K/Akt) appears to be the key factors in upstream pathway (Figure 10) (98), (99). 
PI3K is a lipid enzyme that plays key role in cell proliferation and has been 
demonstrated to be upregulated in malignant cells. PI3K/Akt can phosphorylate BAD 
(Bcl-2-related apoptosis regulatory protein) (100). Akt pathway is particularly important 
because of its role in inhibiting apoptosis and promoting cell proliferation. Akt affects 
the phosphorylation state of BAD (Figure 10). 
 
The activation and downstream signaling of PI3K and Akt is inhibited by tumor 
suppressor gene PTEN. FRAP mediates many signals arising from PI3K and/or Akt like 
signals associated with tumorigenesis (101). Therefore, studying these pathways in detail 
may lead to develop therapeutic strategies against Cancer.         
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Downstream of FRAP 
 
FRAP functions downstream of PI3K/Akt pathway. FRAP plays a role in modulating 
two downstream signaling elements as mentioned earlier: p70
s6k 
and 4E-BPI/PHAS-1 
(102), (103). There are many evidences which indicate that activation of either PI3K or 
Akt- expressing cancer cells, and/or PTEN mutations leads to the phosphorylation of 
both p70
s6k 
and 4E-BPI/PHAS-1which is mediated through the activation of FRAP (104), 
(105). When PI3K- or Akt- expressing cancer cells and cells lacking PTEN suppressor 
function are treated with rapamycin, it blocks the phosphorylation of p70
s6k 
and 4E-
BPI/PHAS-1 and thus inhibiting the cell proliferation. Downstream targets p70
s6k 
and 
4E-BPI/PHAS-1 are described below: 
 
1. 4E-BPI/PHAS-1 
 
It is a low molecular weight protein that represses the protein translation initiation. When 
treated with rapamycin, the phosphorylation of FRAP is blocked and thus the 
phosphorylation of 4E-BPI/PHAS-1. In its dephosphorylated state, 4E-BPI/PHAS-1 
binds to eIF-4E, thus inhibits the translation of mRNAs to important regulatory proteins 
like growth factors, onco-proteins and other cell-cycle regulators (106).   
 
2. p70s6k  
 
This serine-threonine kinase is another target downstream of FRAP. Following 
rapamycin treatment, the phosphorylation of FRAP is inhibited, thus the activation of 
p70
s6k
 protein is blocked which leads to reduced translation of 5‟-terminal 
oligopyrimidine (5‟ - TOP) mRNAs that encode for ribosomal protein, elongation factors 
and insulin growth factor-II. This results in rapid decrease in protein synthesis (107), 
(108). 
Summarizing the whole mechanism, Rapamycin first binds to FKBP12 and then the 
resultant complex binds to FRAP. Thus, inhibiting the activity of FRAP which in turn 
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results in the decrease in the activity of downstream translational regulators p70
s6k 
and 
4E-BPI/PHAS-1. This results in inhibition of protein synthesis and G1 to S phase 
traverse. Due to these effects, Rapamycin inhibits the proliferation of cancerous cells in 
vitro and in vivo.   
 
3.2  Structural details of the complex 
 
The X-ray crystallographic structure of the ternary complex of FKBP12–
rapamycin–FRB has been solved at 2.7 Å resolution by Choi et al. in 1996 (46). Ternary 
complexes of rapamycin derivatives were then crystallized and their structures were 
solved at 1.85 and 2.2 Å resolution by Liang et al. in 1999 (109). The structure of the 
complex is shown in Figure 9. FKBP12 protein consists of a β sheet made of five 
antiparallel β strands. A short α helix is also present. Rapamycin binds in a hydrophobic 
pocket formed between the α helix and β sheet (46). FRB domain of FRAP is composed 
of a bundle of four α helices with rapamycin binding to a hydrophobic pocket formed by 
helices α1 and α4 (46). Chemical structure of rapamycin is shown in the Figure 9 (lower 
panel). It is evident that rapamycin interacts with both receptor proteins. Moreover, 
experimental evidences are available which demonstrates that the FKBP12 protein is 
unable to bind with FRB in the absence of rapamycin (85), (110). To get the deeper 
insight in the interaction network responsible for the binding of rapamycin with FKBP12 
and FRB, we have performed molecular dynamics (MD) simulations and free energy 
calculations on this ternary system. In particular, we have calculated binding free 
energies between the components of the FKBP12–rapamycin–FRB ternary system and 
performed computational alanine scanning (CAS) to evaluate the contribution of each of 
the amino acids at the protein–protein and protein–rapamycin interface to the binding 
energy. 
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CHAPTER 4 
Stabilization of 
FKBP12-FRB complex by 
Rapamycin 
 
 
 
 
4.1  Materials and methods 
 
 The initial structure of the ternary complex, FKBP12-rapamycin-FRB for our 
simulation was retrieved from Protein Data Bank (Protein Data Bank Id: 1FAP) 
determined at 2.7 Å resolution (46). It corresponds to a structure of the complex of 
human FKBP12 and FRB domain of human FRAP with immunosuppressant drug 
rapamycin. Molecular dynamics simulation was performed with Amber 11 package 
(111) using explicit solvent and periodic boundary conditions. Two parameter sets were 
used- Amber99SB force field (112) for the two proteins and Generalized Amber Force 
Field (GAFF) (53) for rapamycin molecule. The system was solvated with TIP3P water 
(113) molecules. SHAKE algorithm (114) was employed to constrain all covalent bonds 
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involving hydrogen atoms to their equilibrium bond lengths, allowing a time step of 1 fs. 
The system was first submitted to 10000 steps of minimization (1000 steps using 
steepest descent method followed by 9000 steps using conjugate gradient method) to 
remove the close contacts in the crystal structure. The systems was then equilibrated for 
100 ps with the number of particles, system volume and temperature constant (NVT 
ensemble) in order to equilibrate the temperature of the system, and subsequently to 100 
ps with number of particles, system pressure (1 atm) and temperature (300 K) constant 
(NPT ensemble) in order to equilibrate the density of the system with a 500 kcal mol
-1
 Å
-
2
 restraint on the positions of Cα atoms. A 20 ns production phase of molecular dynamics 
simulation was then carried out in the NPT ensemble at the same temperature and 
pressure with a time step of 1 fs. Langevin thermostat (115) with a collision frequency of 
5 ps
-1 
has been used to keep the temperature constant. Cα atoms were not restrained in the 
production phase. A 10 Å cut-off for non-bonded Van der Waals interactions was 
applied and Particle Mesh Ewald algorithm (116) was employed to calculate long-range 
electrostatic interactions.  
 The free energy of binding between the components of the ternary complex 
FKBP12-rapamycin-FRB was evaluated using the MM-GBSA approach (117), (118). 
The entropic contribution to binding free energy was evaluated with NMODE module of 
the package AMBER 11. Due to the dimension of the system under consideration, only 
residues at the protein-protein interface and protein-rapamycin interface were considered 
in normal mode analysis, as previously suggested (63), (65). The entropic contribution 
was evaluated on 50 snapshots extracted from last 5ns of the simulation. CAS was 
carried out over snapshots taken at 10 ps intervals from the last 5 ns of the trajectory 
(500 snapshots in total). Each amino acid at the interface was mutated into alanine 
removing all side chain atoms beyond Cβ and replacing it with a hydrogen atom, thus 
obtaining an alanine side chain (119). The interface was defined as the set of amino acids 
with a non-zero difference in solvent accessible surface area (SASA) in the complex 
versus the free proteins. SASA was calculated with the NACCESS software (120). The 
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free energy of binding is calculated using MM/GBSA approach for the wild type and the 
mutated complex.   
 
4.2  Free energy calculations 
Rapamycin acts as a stabilizing agent that allows the association of FKBP12 and 
FRB. From Solvent Accessible Surface Area calculations, we have evaluated the protein 
surface buried upon complex formation, which amounts to 1422 Å
2
. Approximately 50% 
of the buried surface is occupied by rapamycin, which is placed between the two 
proteins. 
In order to understand the interaction network at the detailed atomic level, 
binding free energy calculations and CAS studies were performed. To analyze the 
interface of the FKBP12-rapamycin-FRB complex, a 20 ns MD simulation with explicit 
solvent and periodic boundary conditions has been performed starting from the crystal 
structure.  
We have used MM-GBSA method for the evaluation of binding free energies. 
They perform an a posteriori evaluation of binding free energy on snapshots extracted 
from the MD trajectory to evaluate the binding free energy. In principle, three molecular 
dynamics simulations should be run to calculate binding free energy, one for the 
complex and one for each of the monomers with rapamycin in order to sample their 
conformations. Actually, if the conformations of the isolated monomers do not differ too 
much from their conformations in the complex, a single MD trajectory of the complex 
can be computed, and conformations of the monomers can be extracted from the same 
trajectory. This approach, when the structural modification upon binding are not 
extensive, is accurate and has the advantage to be less computationally expensive and 
provides results with a lower statistical uncertainty (121). Please refer to the section 2.2.1 
for detailed theory behind free energy calculation by MM-GBSA method.  
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When performing binding free energy calculations with the MM-GBSA method, 
it is customary to define a receptor and a ligand unit in the system, between which the 
binding energy is evaluated. In this work, we have three molecules, two proteins and 
rapamycin, so two sets of free energy calculation and CAS studies have been performed, 
in the first case considering rapamycin as a part of the FKBP12 unit, the second one 
including rapamycin in the FRB unit. Binding free energy of each of the proteins with 
rapamycin and between the two proteins in the absence of rapamycin were also 
calculated using single trajectory MM/GBSA method (Table 1). Entropic corrections 
have also been evaluated. While the molecular mechanics energy term can be easily 
obtained from the results of a molecular dynamics simulation, the entropic term is often 
difficult to achieve. It can thus be approximated to ΔSvib, i.e. the contribution due to the 
internal vibrations, whose calculations are nonetheless usually time-consuming and can 
be affected by large statistical uncertainty (65). The relative contribution of the change in 
conformational entropy to the ΔΔG is considered to be negligible for the mutational 
studies, since it is supposed to cancel up when calculating it in the native and in the 
mutated complex, as in CAS studies (74). For the details of entropic calculations, please 
refer to section 2.2.1.  
The entropy corrected value of average binding free energy referred to the first 
case (rapamycin considered as a part of the FKBP12 unit) is estimated to be -28.59 ± 
2.42 kcal mol
-1
 (value ± S.E.M.), and for the second case (rapamycin considered as part 
of the FRB unit), it is found to be -29.30 ± 2.32 kcal mol
-1
. Entropy values calculated 
with normal mode analysis are affected by large errors and can be considered as semi-
quantitative, it is anyway interesting to notice that the entropy corrected average binding 
free energy between FKBP12 and FRB in the absence of rapamycin turned out to be 
+25.45 ± 2.79 kcal mol
-1
, a positive value suggesting the impossibility of the formation 
of a binary complex between the two proteins. The value of the binding free energy for 
the ternary complex (FKBP12.RAP.FRB) can be obtained by adding the binding free 
energy for the first case (FKBP12.RAP + FRB) and binding free energy between 
FKBP12 and rapamycin, thus resulting to be -55.30 ± 4.26 kcal mol
-1
. Likewise, adding 
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ΔG for the second case (FKBP12 + RAP.FRB) and ΔG between FRB and rapamycin, we 
get an almost identical value -55.72 ± 3.91 kcal mol
-1
. These data suggest that the ternary 
complex is stable only in the presence of rapamycin, that is in agreement with the 
experimental observations which report that the formation of the FKBP12-FRB complex 
is strictly rapamycin dependent. (85), (110). 
It is worth noting that, even if only half of the protein surface buried upon 
ternary complex formation is occupied by rapamycin (see above), the binding free 
energy between FRB and rapamycin is almost equivalent to the binding free energy 
between the FKBP12-rapamycin complex and FRB, implying that the direct protein-
protein interaction is negligible and the binding is completely mediated by rapamycin. 
The same observation is valid for the FKBP12-rapamycin interaction, which is, 
considering statistical uncertainty, almost identical to the interaction between the 
FKBP12 itself and the FRB-rapamycin complex (see Table 1). All the data obtained 
from free energy evaluations show that rapamycin can be thought to act as a bridge 
between FKBP12 and FRB. The details of this bridging action will now be further 
investigated. 
 
Systems ΔG (without entropy) 
(kcal mol
-1
) 
Mean ΔG ± S.E.M. 
ΔG (with entropy)  
(kcal mol
-1
) 
Mean ΔG ± S.E.M. 
FKBP12.RAP + FRB  -69.69 ± 0.19 -28.59 ± 2.42 
FKBP12 + RAP.FRB  -76.58 ± 0.20 -29.30 ± 2.32 
FKBP12 + FRB -21.35 ± 0.16 +25.45 ± 2.79 
FKBP12 + RAP -54.91 ± 0.15 -26.71 ± 1.84 
FRB + RAP -48.02 ± 0.09 -26.42 ± 1.59 
 
Table 1: Binding free energy values (given in kcal mol
-1
) calculated with MM-GBSA method for 
all the cases considered. RAP stands for rapamycin.  
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4.3  Computational Alanine Scanning Studies 
 
The calculation of the binding free energy allows to perform a CAS analysis of 
the protein-protein interface, in order to highlight the residues that contributes 
significantly to protein-protein binding (hot-spots, for details refer to the section 1.2.2) 
and to analyze the interaction network of the ternary complex at the atomic level. The 
calculation is performed by evaluating the binding free energy between the protein 
subunits making up the complex (ΔGWT) and the binding energy upon mutation of each 
interfacial amino acid into an alanine (ΔGmut,X), so, for each residue, a ΔΔG value can be 
obtained as 
     ΔΔGX = ΔGmut,X – ΔGWT 
Also in this case, in principle two MD trajectories should be computed, one for 
the wild type and other one for the mutated complex. This would require performing a 
different MD simulation for each of the point mutations to be sampled in the complex, 
leading to a substantial number of simulations for a large surface. It is possible to make 
the hypothesis that a single point mutation does not significantly affect the structure of a 
protein or of a protein-protein complex. This is a strong approximation, because at least 
locally the protein structure may be modified by the substitution of an amino acid, but in 
general it is rather accurate. It is therefore possible to use the so-called single-trajectory 
approach to perform the computational alanine scanning. According to this procedure, a 
single molecular dynamics simulation is performed on the protein complex, then a set of 
snapshots is extracted from the trajectory for the ΔGWT evaluation. Subsequently on the 
same snapshots point mutations are introduced one at a time and the ΔGmut,X is calculated 
for each of the amino acids at the protein-protein interface, and ΔΔGX is easily obtained 
(74). The single trajectory approach proved to be rather accurate, but it tends to 
overestimate ΔΔGX  for charged residues. This problem can be limited by associating a 
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dielectric constant greater than 1 (usually between 2 and 4) to the protein, mimicking the 
dielectric properties of protein interiors (117) 
We have performed CAS using MM-GBSA approach. Also for CAS, we have 
considered rapamycin as belonging either to the FKBP12 or to the FRB unit, thus 
obtaining two ΔΔG values for each amino acid. CAS was carried out over snapshots 
taken at 10 ps intervals from the last 5 ns of the MD trajectory thus resulting in 500 
snapshots in total. For the implementation of CAS, only amino acids located at the 
protein-protein interface were considered. Thus, the so defined interface comprises 38 
residues in total, 21 residues on the FKBP12 and 17 on the FRB protein. From the 
analysis of the CAS results, it is clear that the binding free energy is not distributed 
uniformly on the protein-protein interface, but it is concentrated to some critical residues 
(Figure 11). These amino acids tend to be grouped into small clusters on the interface 
and they are classified on the basis of difference in binding free energy between the wild 
type and mutant type as hot spots (ΔΔG > 4 kcal mol-1), warm spots (2 kcal mol-1 < ΔΔG 
< 4 kcal mol
-1
) and cold spots (ΔΔG < 2 kcal mol-1).  
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Figure 11: Hot and warm spot distribution at protein-protein interface. Different colors from 
green to red refer to the variation in the binding energy of complex upon mutation of each of the 
residues at interface. Hot and warm spots thus identified are shown. Figure 11a and 11b 
represents the distribution of hot and warm spots when rapamycin is considered as a part of 
FKBP12. Figure 11c and 11d represents the distribution of hot and warm spots when rapamycin is 
considered as a part of FRB. Rapamycin is shown in blue.   
 
It is clear from Figure 11a that, despite rapamycin occupies only half of the 
buried surface of FKBP12, the protein shows only one warm spot, whereas on its binding 
partner FRB (Figure 11b), there are several hot and warm spots distributed at the 
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interface. Similarly, when rapamycin is considered as a part of the FRB unit (Figure 
11d) and covers a similar proportion of the protein buried surface, FRB shows only one 
hot spot while protein FKBP12 exhibits a few hot and warm spots (Figure 11c). The two 
sets of calculated ΔΔG values for the 38 residues building up the interface are reported in 
Figure 12. 
It can be observed in Figure 12 (ΔΔG values are given in Table 2)that most of 
the residues exhibited a very large difference in their ΔΔG values depending on which 
protein (FKBP12 or FRB) rapamycin is associated to in the CAS procedure (red and blue 
bars respectively). This indicates that the residue which is estimated as hot/warm spot 
when rapamycin is considered a part of the FKBP12, are not found to be a hot/warm spot 
when it is a part of the FRB unit and vice versa. Thus, it implies that most of the amino 
acids at the interface interact with rapamycin. In very few residues, there is a minor 
reduction in ΔΔG values for the two cases considered, which suggests that these residues 
directly interact with the protein partner. Interestingly, out of 15 hot/warm spots found at 
the protein interface, only two, namely His87 and Arg2042 are found in both sets of data, 
thus mediating a direct protein-protein interaction.  
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Residues FKBP12.RAP + FRB FKBP12 + RAP.FRB 
ΔΔG (Kcal mol-1) S.E.M. ΔΔG (Kcal mol-1) S.E.M. 
Thr21 0 0.001 0.01 0.001 
Tyr26 0.1 0.003 2.75 0.084 
Phe36 0.09 0.003 1.79 0.086 
Asp37 0.17 0.014 1.43 0.176 
Arg42 1.72 0.163 2.56 0.189 
Lys44 0.27 0.064 0.26 0.064 
Phe46 1.05 0.068 4.37 0.112 
Lys47 0.38 0.045 0.41 0.047 
Phe48 0.07 0.001 0.42 0.011 
Gln53 -0.03 0.003 0.28 0.027 
Glu54 -0.18 0.016 1.39 0.103 
Val55 0.06 0.001 1.72 0.069 
Ile56 0.08 0.003 2.54 0.077 
Trp59 0.08 0.001 3.4 0.074 
Tyr82 0.69 0.037 4.91 0.196 
Thr85 0.65 0.069 0.65 0.069 
His87 3.07 0.147 5.04 0.123 
Pro88 1.5 0.089 1.58 0.090 
Ile90 0.61 0.061 1.69 0.097 
Ile91 0.07 0.001 0.68 0.064 
Phe99 0.05 0.001 2.05 0.079 
Leu2031 0.4 0.019 0.02 0.001 
Glu2032 1.05 0.084 0.14 0.027 
Ser2035 0.82 0.099 0.04 0.001 
Arg2036 0.91 0.053 0.02 0.006 
Tyr2038 1.25 0.063 0.86 0.061 
Phe2039 6.83 0.116 1.07 0.056 
Arg2042 6.22 0.232 6.12 0.230 
Val2094 1.4 0.092 1.37 0.092 
Lys2095 0.81 0.172 0.8 0.170 
Thr2098 1.5 0.092 0.43 0.034 
Trp2101 2.62 0.082 0.15 0.006 
Asp2102 1.17 0.128 0.91 0.123 
Tyr2104 0.17 0.004 0.02 0.001 
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Table 2: ΔΔG values for the residues at the FKBP12-FRB interface in both cases (FKBP12.RAP + 
FRB) and (FKBP12 + RAP.FRB) calculated by Computational Alanine Scanning. Hot and warm 
spots are reported in bold characters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tyr2105 6.17 0.136 1.97 0.094 
His2106 0.15 0.021 0.13 0.021 
Phe2108 2.87 0.108 0.14 0.012 
Arg2109 0.83 0.095 0.63 0.099 
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Figure 12: ΔΔG values obtained from CAS considering rapamycin as a part of 
FKBP12 (red bars) or as a part of FRB (blue bars). 
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4.4  Analysis of the Interaction Network  
 
On analyzing the environment of CAS estimated hot and warm spots during the 
simulation, it is found that they participates in a network of interactions including 
hydrogen bonding, hydrophobic contacts and salt bridges. Rapamycin binding site on 
FKBP12 is delimited by a cluster of residues: Trp59, Phe99, Tyr26 and Phe46. These 
residues are estimated to be hot or warm spots by our CAS studies and they interact with 
pipecolinyl ring (C2 to N7, Figure 9) of rapamycin hydrophobically (Figure 13c). This 
agrees with the crystallographic structure of the ternary complex reported by Choi et al 
(46) and also with the crystal structure of the FKBP12-rapamycin binary complex (122). 
The most prominent hot spots belonging to the FKBP12 protein are Phe46, Tyr82 
and His87. These residues were characterized by high ΔΔG values (4.37 kcal mol
-1
, 4.91 
kcal mol
-1
 and 5.04 kcal mol
-1 
respectively). Phe46 hydrophobically interacts, as we 
pointed out, with rapamycin, while Tyr82 interacts via a stable hydrogen bond. Hydroxyl 
group of side chain of Tyr82 forms a hydrogen bond (average bond length 2.65 Å) with 
carbonyl oxygen at C8 of rapamycin that is populated for 82% of the analyzed MD 
trajectory (Figure 13a), which is in agreement with crystallographic structure  (46), 
(109). His87 which is predicted to be a hot spot (refer to Table 2), interacts with pyranose 
ring of rapamycin hydrophobically. Interestingly, His87 has been experimentally found to 
interact with the pyranose ring of the ligand FK506 which is structurally similar to 
rapamycin (123). In addition, backbone nitrogen of Ile56, a warm spot (ΔΔG 2.54 kcal 
mol
-1
) interacts with carbonyl oxygen at C1 of rapamycin via a further hydrogen bond 
(Figure 13b). The average bond length of this hydrogen bond is 2.9 Å and is found to be 
populated for 73% of the analyzed trajectory. This interaction agrees with the 
crystallographic structure (46), (109). Three more hydrogen bond interactions have been 
observed between FKBP12 and rapamycin, namely Gln53 main chain carbonyl with C40 
hydroxyl of rapamycin, Glu54 main chain carbonyl with C28 hydroxyl and Asp37 
carboxyl oxygen with C10 hydroxyl. These interactions are predicted by CAS to give 
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only a little contribution to the binding of FKBP12 and rapamycin, considering that the 
aforementioned residues exhibit ΔΔG values around 1 kcal mol-1 in our study.    
 
 
Figure 13: Details of network of interactions between FKBP12 and rapamycin (a,b and c)and 
between FRB and rapamycin (d) are displayed. Key hydrogen bonds are highlighted between 
FKBP12 and rapamycin (a and b). Hydrogen bonds are represented with blue dotted lines. A 
network of residues are involved in hydrophobic contacts between rapamycin and FKBP12 (c) 
where Trp59 is represented in purple, Tyr26 is represented in yellow, Phe46 is represented in green 
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and Phe99 is represented in blue. A network of residues involved in hydrophobic contacts between 
rapamycin and FRB are shown (d) where Phe2039 is represented in yellow, Trp2101 in red, Tyr2105 
in purple and Phe2108 in green. FKBP12 protein is shown in red cartoon representation. FRB 
protein is shown in blue cartoon representation. Key residues are shown in ball and stick model. 
Rapamycin is shown in ball and stick representation in standard atom colors with Carbon atoms 
colored in cyan, nitrogen in blue, oxygen in red and hydrogen in white. 
 
The most important hot spots on the interface of FRB are Phe2039 and Tyr2105 as 
represented by their high ΔΔG values 6.83 kcal mol-1 and 6.17 kcal mol-1 respectively. 
Other important residues that are estimated to be warm spots are Trp2101 and Phe2108. 
These aromatic residues, that lined a hydrophobic cavity on the surface of FRB, 
hydrophobically interact with triene arm of rapamycin (C16 to C23, Figure 9). This 
cavity is shallower than the rapamycin binding pocket on FKBP12 and the interactions 
between FRB and rapamycin are completely hydrophobic in nature (Figure 13d).    
The results obtained in this study have shown that there are extensive 
interactions between FKBP12 and rapamycin and between FRB and rapamycin, but very 
limited interactions are observed between the two proteins. Only two significant direct 
interactions between FKBP12 and FRB have been observed. One of them is the 
hydrogen bond between the side chain of Arg2042 of FRB and main chain carbonyl 
oxygen of Gly86 of FKBP12 (Figure 14a). This hydrogen bond is populated for 81% of 
the analyzed trajectory and the average bond length is 2.83 Å. Arg2042 is estimated to be a 
hot spot with ΔΔG value of 6.22 kcal mol-1 by CAS studies. This hydrogen bond 
interaction was not observed in previous crystallographic studies (46), (109). In addition, 
side chain of Arg42 on FKBP12 formed a stable salt bridge with side chain of Asp2102 
during the whole trajectory, (109) (Figure 14b). Analysis of the CAS results and 
interaction network analysis of this ternary complex are in agreement with the 
experimental observation by L.A. Banaszynski et al (85). With the help of fluorescence 
polarization and surface plasmon resonance techniques, they have shown that the 
complex is stable only in the presence of rapamycin since key residues on the interface 
of the two proteins strongly interact with rapamycin and make few interactions with one 
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another. This is also coherent with the bridging action of rapamycin suggested by 
binding free energy calculations described in this work. 
 
Figure 14: Details of interaction network between FKBP12 and FRB. Hydrogen bond is 
highlighted between Gly86 of FKBP12 and Arg2042 of FRB (a). Salt bridge between Arg42 of 
FKBP12 and Asp2102 of FRB is depicted (b). Rapamycin is represented in yellow.  
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Conclusions 
 
In the present work, we described how a small molecule can induce the 
formation of an otherwise unstable protein–protein complex by a direct, bridging 
mechanism, even if it covers only a limited portion of the protein–protein contact 
surface. The reported results and the good performance of standard molecular modeling 
techniques in describing our model system can be interesting not only in the design and 
development of improved molecules acting as FKBP12–FRB protein interaction 
stabilizers, but also in the somehow neglected study of PPIs stabilizers in general. 
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PART II 
 
 
 
 
 
 
 
 
 
 
Computational Modeling of the 
Application of Mechanical Force to 
the Biomolecules 
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CHAPTER 5 
COMPUTATIONAL METHODS II 
 
 
5.1  Steered Molecular Dynamics 
 
Some biological processes are slow and inaccessible at natural time scale. They 
can be made accessible to the molecular dynamics time scale by Steered Molecular 
Dynamics (SMD) technique. For instance, the unbinding of ligand from the receptor, 
conformational change of the biomolecules, protein folding and unfolding, study of 
dissociation pathway of a protein dimer and explanation of mechanics of biopolymers. 
Some of the applications will be discussed later in this section. 
Despite an abundance of computational methods for the protein/enzyme–ligand 
interaction and protein-protein interaction, little is known about their pathways; i.e how a 
ligand binds to a protein or how the two proteins interact with each other. Presently, the 
main point of view concerning molecular simulations describing ligand binding and 
determining binding affinities of ligands, is to try for the ideal of reversibility, which is 
realized in umbrella sampling and free energy calculations (124), (125), (126). But 
reaching this ideal is a slow process and requires expensive simulations. A new 
computational method which accepts irreversibility is SMD, is useful in this case (127). 
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In short, SMD accelerates the processes to simulation time scales (ns) with the help of 
time-dependent external force applied on the system.  
The fundamental idea behind SMD is inspired from the experimental techniques 
which are based on the principle of application of mechanical forces to single molecule 
in small assemblies. These techniques are Atomic Force Microscopy (AFM) (128), 
optical tweezers (129) and biomembrane force probe (130). The principle of AFM is 
described in Figure 15. These techniques have been applied to the study of binding 
properties of biomolecules and their response to external mechanical stimulations (131).  
 
 
Figure 15: An illustration of the working principle of AFM. This figure is adapted from 
(132) 
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In SMD, external force is applied to the system to perform the desired process. 
In the case of dissociation of a complex comprising two interacting species, a series of 
configurations are generated along a reaction coordinate, between two interacting 
species. One of the species is considered as reference, and the other species is placed at 
increasing center of mass (COM) distance from the reference (133). SMD simulations or 
COM pulling can be used to bias the behavior of a system towards a particular 
phenomenon that is not accessible on the time scale of conventional MD. The external 
force applied to one of the interacting species is required to restrain that species to a 
point in space (restraint point) by an external potential (e.g. harmonic potential). The 
restraint point is then shifted in a selected direction, forcing that species to move from 
initial position and explore the new positions in the dissociation path (134), (135), (136). 
In the case of protein/peptide unfolding, external potential is applied on a terminal atom 
of the structure while the other terminal atom is considered fixed. 
Assume a reaction coordinate x, and an external potential U, 
   
(    )
 
 
 
Where, K is the stiffness of the restraint,    is the initial position of the restraint point 
moving with a constant velocity v, the external force applied on the system can be 
expressed as: 
    (       ) 
 F represents the force by which the interacting species is pulled by a harmonic spring of 
spring constant K with its end moving with velocity v.  
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Forces apart from harmonic potential can also be used according to the processes 
concerned, e.g. constant forces, surface tension or torque. SMD simulation requires 
selection of the path, i.e. a series of directions of the applied force. For some cases, path 
could be a straight line and for some other cases, the path is not straight. In study of the 
unbinding of avidin-biotin complex (137) and unfolding of titin immunoglobulin 
domains (138) the path of dissociation and unfolding respectively is straight. In the case 
of biomolecular systems where the ligand is situated at the bottom of the binding cleft, 
e.g. In pulling of a single bacteriorhodopsin out of a membrane (139) and unbinding of 
substrate from prostaglandin H2 synthase (140), the direction of force is not straight and 
same throughout the unbinding process, it should be changed to avoid distortion of the 
surrounding protein. The direction of the force can be chosen randomly according to the 
structural information. Then the force is applied in the selected direction. The force 
applied is accepted or rejected based on the factors like conservation of the secondary 
structure of the protein, the magnitude of the applied force, velocity by which the ligand 
moves etc.  (135), (127)  
SMD: Basic steps         
1. Generate hypothesis of the conformational transition. Select the reaction 
coordinate. 
2. Apply forces that induce the hypothetical process during reasonable time. 
3. Analyze results to test the working hypothesis.   
 
Applications of SMD on biomolecules 
 
Application area of SMD is vast which includes unbinding of the ligand from the 
protein, protein-protein interactions, extraction of lipids from membranes (141) and 
describing the elastic properties of the proteins. Application of an external force causes 
the displacement in the simulated system, which allows for the calculation of work (a 
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path dependent quantity). In the case of a complex, the analysis of the applied force and 
system‟s position with respect to the time; and the details about the interactions between 
the two interacting species gives important information about the structure-function 
relationship of the interacting species. On the other hand, in the case of unfolding of a 
peptide, analysis of the applied force and position of the „pulled‟ atom (on which 
external force is applied) with respect to time gives insight into the stability of the 
peptide. SMD not only yields qualitative information, but also quantitative information 
about the binding free energy or the unfolding free energy depending upon the case. Two 
applications are discussed briefly as follows:   
 
1. Unbinding of biotin from Avidin-biotin Complex (137): Avidin-Biotin is a protein-
ligand system which has been studied extensively by Atomic Force Microscopy 
experiments. In 1997, Israilev et al have studied the microscopic detail of unbinding of 
the ligand biotin from protein avidin by using SMD technique with force constants close 
to those of AFM cantilevers. They have compared the results of SMD simulation with 
that of AFM experiments. Avidin is a tetrameric glycoprotein and Biotin is a vitamin 
molecule which acts as an activated CO2 carrier in some physiological pathways. Avidin 
can bind upto four molecules of biotin due to its tetrameric structure. The binding 
affinity of biotin to avidin is reported enormously high (binding free energy of about 20 
kcal/mol (142), (143) and binding constant kd = 10
-15
 (144). In this simulation, 
dissociation was performed by means of harmonic restraint (K ranging from 0 to 
120pN/Å). The force grows almost linearly with time, similar to the results reported in 
AFM experiments (145). They have shown that during the process of unbinding, biotin 
move in discrete steps due to the formation and rupture of hydrogen bonds at each step. 
The results found were consistent with the experimental studies.        
                
2. Unfolding of I1 domain of Titin (146): One of the applications of SMD is to explore the 
energetic barriers to mechanical unfolding of proteins, which is in principle similar to the 
mechanical pulling of a single molecule in AFM. Although MD simulations are widely 
applied for the study of protein dynamics, the commonly available computational power 
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can only simulate systems for hundreds of nanoseconds. Unfortunately, the biological 
processes which includes large conformational changes, takes place on timescales of 
milliseconds to seconds. Unfolding of titin is such a process and it has been studied by 
implementing SMD technique, where a force is applied to the starting conformation and 
new conformations were generated by along a reaction coordinate. In this study, authors 
have reported SMD simulations for the unfolding of I1 domain of titin. They have 
performed the studies on both oxidized and reduced I1 domain of titin, latter form is 
devoid of a disulfide bridge between two β-strands. Previously, I27 domain of titin (an 
immunoglobin domain) has been studied well experimentally exploiting AFM technique 
and computationally using SMD. (147). Mechanical pulling of I27 domain on the 
microscopic level is also explored using SMD (148) (149).  
 
Due to the limitation of currently available computational resources, the 
timescale accessible to SMD simulation, i.e. nanoseconds, is shorter than that of AFM 
experiments, which is in milliseconds, by six orders of magnitude. This gap in the 
timescale requires a pulling velocity used in simulations about six order of magnitude 
faster than in experiments, which leads to the discrepancy in the unfolding forces as 
shown in previous studies (150), (149). This problem can be solved by using reduced 
pulling velocities close to experimental values, which however requires expensive 
computational simulations. 
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5.2  Umbrella Sampling and Weighted Histogram 
Analysis Method 
The major challenge in simulations is that of sampling of the conformational 
space. Molecular Dynamics are just not sufficient to sample the entire conformational 
space unless run for a very long time. And due to the limitation of computational power 
available, sampling is very difficult using conventional MD. In order to measure the 
entire available space in larger systems, extensive sampling is needed. That is why 
Umbrella sampling method is used by which one can bias or force the system to sample a 
particular region(s) based on some reaction coordinate (ξ). (151) 
The canonical partition function (Q) for a given reaction coordinate (ξ) is given 
by: 
 
 ( )   
∫  [ ( )    ]     [(   )   ]
∫     [(   )   ]
 
Where, E is the potential energy. 
    
 
   
     kb is the Boltzmann‟s constant  
The above equation allows for the calculation of potential of mean force (PMF) 
 ( ) along a reaction coordinate.  
 ( )    
 
 
   ( ) 
PMF can be described as the potential that gives an average force over all the 
configurations of a system. In computer simulations, if every point in phase space is 
visited during the simulation process, PMF can be directly calculated from molecular 
dynamics simulation by monitoring the distribution of the system along the reaction 
coordinate. But simulations run for finite lengths of time and hence exact ensemble 
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average cannot be achieved. Regions in conformational space around a minimum are 
sampled well whereas regions of higher energy are sampled rarely.  To obtain a complete 
profile for PMF calculation these high energy regions are required. 
Umbrella sampling or biased molecular dynamics is an accelerated sampling technique 
used to calculate free energy. This sampling technique was developed by Torrie and 
Valleau (152). Here, bias potentials along a reaction coordinate drive a system from one 
thermodynamic state to another. The bias ensures an efficient sampling along the whole 
reaction coordinate. The effect of this bias potential in connecting energetically separated 
regions gave rise to the name „umbrella sampling‟. The intermediate states are covered 
by windows and independent molecular dynamics simulations are performed in each 
window. For a better sampling, a proper choice of the reaction coordinate is more 
important. If the reaction coordinate misses important structural changes, it can lead to 
artificial change in the results. A much higher barrier may result in unfavorable path 
being taken. A much lower barrier may be the result of discontinuities in the path. 
Unbiased free energy is calculated by 
  ( )    (  ⁄ )    
 ( )     ( )      
Where, wI(ξ) is the bias potential for window i and is analytically given. 
   
 ( ) is the normalized frequency of finding the system in the vicinity of a given value 
of ξ 
Fi =  (  )       [    ( )]  ⁄  and is independent of ξ.  
Thus, with the assumption that the sampling in each window is sufficient and 
appropriate choice of umbrella potential is made, the PMF can be measured as long as 
the window spans the whole range of ξ and unbiased PMF can be calculated.  
Bias potential choice in ideal condition is such that sampling along the reaction 
coordinates is uniform. 
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i.e. wopt = -A(ξ).  
wopt is the bias potential at optimal condition. 
As A(ξ) is not known a priori, various methods have emerged for the estimation 
of bias potential. 
Harmonic bias potential is a commonly used bias potential for a series of 
windows. In each window a bias function is applied to keep the system close to the 
reference point. A simple harmonic bias of strength K is used: 
  ( )     ⁄  (     
   )  
The choice of K is a critical decision and has to be made before the simulation run. 
Overall K has to be large enough to drive the system over the barrier. If K is too large 
then configurations with high energies will be overrepresented. 
Adaptive bias potential starts with an initial guess of w(ξ) and iteratively 
improves it to achieve a uniform distribution. Other specialized umbrella potentials have 
also been used. 
The function Fi, a component in the calculation of the unbiased free energy 
potential, has to be calculated for global PMF. However this function cannot be directly 
obtained from sampling. A number of methods have been used to analyze the umbrella 
sampling simulations i.e. to combine the results of different windows in umbrella 
sampling; the promising one being Weighted Histogram Analysis Method (WHAM). 
 Weighted Histogram Analysis Method (WHAM) is an extension of the 
Ferrenberg and Swendsen‟s Multiple histogram technique (153) which was first used on 
biomolecules by Kumar and coworkers (154). WHAM is based on the use of multiple 
histograms generated from NVT simulation. Here, a histogram is a probability 
distribution of the total energy of the system. In such technique, histograms at different 
parameters or one histogram at a particular value of the specific parameter are combined 
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to form a single histogram. It has been implemented in various studies to determine the 
free energy of a system. 
The main advantages of this method are  
(a) built-in estimate of sampling errors,  
(b) yields the best value of free energies by taking into account all simulations, 
thus minimizing statistical errors and  
(c) allows multiple overlaps of probability distributions for obtaining better 
estimates of free energy differences. 
The global distribution is calculated by a weighted average of the distributions of 
individual windows: 
  ( )   ∑   ( )  
 ( )
       
 
 
Where the weight pi is chosen to minimize the statistical error, leading to 
 
   
  
∑    
 
and    ( )         [    ( )     ] where Ni is total number of steps sampled for 
window i. 
Fi is calculated as: 
   (    )   ∫ 
 ( )     [    ( )]   
Since in the above equations both Fi and P
u
 are present, these have to be iterated until a 
convergence is achieved. 
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CHAPTER 6 
MODELLING THE EFFECT OF 
OSMOLYTES ON PEPTIDE 
MECHANICAL UNFOLDING 
 
 
 
Abstract 
In this work, we have studied about how the osmolyte molecules affect the mechanical 
unfolding of a peptide. Mechanical unfolding has been performed by using Steered 
Molecular Dynamics and free energy of a model peptide has been obtained from 
umbrella sampling and weighted histogram analysis method. The effect of four different 
osmolytes on the free energy difference between the folded and the denaturated state 
have been calculated. The observed trend mirrors the expected behavior of the studied 
osmolytes and unfolding pathways analysis allows an insight in the osmolyte action 
mechanism. 
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6.1  Osmolytes and Protein Stability 
 
Osmolytes are small soluble molecules found in the cellular fluids which 
maintain the cellular volume and fluid balance by the effect of osmosis. Osmolyte 
molecules can be classified in two different groups with respect to their effect on protein 
stability: osmoprotectants and denaturants. Osmoprotectants stabilize the protein or 
peptide in their folded state. On the other hand, denaturants favour the denatured state of 
the peptides or proteins. Nature developed a large number of strategies in order to allow 
plants and animals to survive in extremely severe condition such as extreme 
temperatures, high pressures or high salinity. One of these strategies is the accumulation 
of small, highly soluble molecules in cellular fluids in such resistant organisms, because 
of these molecules, the osmotic stress of cells is reduced; such molecules are 
osmoprotectants. Several barophilic bacteria, as Psychromonas haladis, proliferate 
optimally at 50 MPa pressure (155), while Methanopyrus kandleri, a hyperthermophilic 
organism can survive at temperature as high as 120 ºC. (156) Some angiosperms, for 
example, the famous resurrection plants, which shows drought tolerance and are able to 
„die‟ in the dry season and to „resurrect‟ in the rainy one (157), (158).  
Osmoprotectants, also called compatible solutes due to the high concentration 
they can reach in living organisms without toxic effects, are small organic molecules, 
typically amino acids or polyols (159). These molecules have also shown activity in 
protein stabilization against either thermal or chemical denaturation (160). Besides their 
biological function, osmoprotectants have a key role in very different agricultural and 
industrial fields. For example, in agriculture the development of plants capable of 
synthesizing this type of compounds could lead to the development of species more 
resistant to drought and requiring lower amounts of water for irrigation, with all of the 
benefits easily imaginable. In the cosmetic field, osmoprotectants are used as 
components of products aimed at protecting the epithelial from dehydration and drying. 
Moreover, the ocular pharmacology could be cited as a field where osmoprotectants have 
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recently found application in the treatment of dry eye, to compensate extracellular 
hyperosmolarity without interfering with cellular metabolic processes (161). 
Although the osmoprotectants are widely used in different fields, their exact 
molecular action to protein stability is still unknown. They can hinder both thermal and 
chemical denaturation, the latter induced by molecules such as urea and guanidinium 
chloride that acts as protein denaturants. Two different hypotheses have been developed 
to rationalize the effect of osmoprotectants and denaturants. One tries to explain 
osmoprotection and denaturation invoking a direct mechanism in which the osmolyte 
directly interact with the protein backbone and side-chain varying its stability (162), 
(163), (164), (165). The second hypothesis focus its attention to the structure and role of 
the solvent: denaturants weaken water structure allowing a better solvation of 
hydrophobic residues while osmoprotectants strengthen hydrogen bond network in the 
solvent achieving the opposite effect (166), (167), (168), (169), (170), (171). There are a 
lot of computational and experimental data supporting each theory, but which is the most 
probable driving force is still a matter of debate (160), (166).  
The work described here is about the computational determination of the 
mechanical unfolding free energy difference for a reference system, a small peptide in 
pure water, and in the presence of different osmolytes, both osmoprotectants and 
denaturants. The reference peptide used is the β-hairpin fragment of G protein B1 
domain (Figure 17a) (172). This peptide has been chosen because its folded state is 
stable in water at biological condition and it is largely studied both computationally and 
experimentally (173), (174), (175). Osmoprotectants used are glycine betaine and ectoine 
that should contrast the denaturation process, increasing the free energy difference, while 
the denaturants used are urea and guanidinium chloride which should decrease the free 
energy difference making denaturation easier than in pure water. Structural formula of 
each osmolyte is shown in Figure 16. 
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Figure 16: Structural formulae of the four used osmolytes: (a) glycine betaine (GBE); (b) ectoine 
(ECT); (c) urea (URE); (d) guanidinium (GUA). 
 
 
 
 
 
 
Figure 17: (a) Structure of the β-hairpin showing two antiparallel β-sheets connected by a loop. 
(b) The illustration representing the application of mechanical force on the peptide. 
 
 
The calculated mechanical unfolding free energy corresponds to the free energy 
difference between an initial state, corresponding to the folded state of the peptide and a 
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fully extended final state. The reaction coordinate chosen to describe the process is the 
distance between the α carbon of the first and α carbon of the last amino acid of the 
peptide. In the initial state the distance is about 0.4 nm, while in the final state the 
distance from first and final alpha carbon is maximum, about 4 nm. The elongation 
process has been simulated via steered molecular dynamics (SMD) (refer to the section 
5.1). Since, the steering is mechanical, so for this reason the obtained potential of mean 
force (PMF) could not be interpreted as the thermally unfolding free energy profile, but 
as a mechanical free energy along a specific pathway. It‟s worth pointing out that from 
SMD it is not possible to get the PMF, unless equilibrium dynamics are performed. 
Thus, different sampling algorithms have to be used, algorithms allowing a better 
sampling of the whole pathway, which results in a more accurate estimate of the PMF. 
 
The way found to sample the entire range of distance, the reaction coordinate ξ, 
is the umbrella sampling method (refer to section 5.2) originally proposed by Torrie and 
Valleau (176). In this method a set of dynamics is performed, restraining the reaction 
coordinate to successive values of a reference distance ξi. The restraining potential 
usually employed is harmonic: 
 
  ( )  
  
 
(    )
 
 
Where, Ki is the strength of the potential and ξi is the reference position of the restrain. 
The aim of all the dynamics is to significantly sample the complete reaction path by 
using the sampling algorithm, „Umbrella sampling‟. From each run a histogram is 
recorded as a function of ξ and the PMF is calculated based on such distribution (177). 
However, the calculated PMF curves are biased by the wi(ξ) potential and so the obtained 
histograms have to be reweighted to remove the bias. The weighted histogram analysis 
method (WHAM) proposed by Ferrenberg and Swendsen (153), and later applied to 
biological systems by Kumar (154) has been used. This method have the great advantage 
of providing the best possible PMF making use of all data obtained by simulations; 
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overlap between contiguous windows are not discarded as in other methods, but are 
efficiently used to improve the PMF. 
 
6.2  Materials & Methods 
The model system chosen is the β-hairpin fragment of G protein B1 domain 
(Protein Data Bank Id: 2GB1) corresponding to residues from GLY41 to GLU56. The β-
hairpin has been simulated in a water box of 5 × 5 × 8 nm
3
 using periodic boundary 
condition. The largest dimension of the box corresponds to the z direction along which 
the β-hairpin is unfolded. The system is solvated using explicit water with the TIP4P 
model (113), which has been reported to contribute to a better description of the 
conformation of peptides in water (178). Three sodium ions were added to assure system 
neutrality. Electrostatic interactions were simulated using Particle Mesh 
Ewald (179) with a cutoff of 1.4 nm; the same cutoff was used for van der Waals 
interactions. This is referred to as the reference system since no osmolytes were added. 
 
Four more systems have been set up with the same methodology. In each of 
them 241 molecules of osmolyte were randomly placed inside the box in order to obtain 
a 2 M solution. The osmolytes used are: glycine betaine (GBE) and ectoine (ECT) as 
osmoprotectants, urea (URE) and guanidinium chloride (GUA) as denaturants. To 
achieve system neutrality where guanidinium cations are used, for each molecule of 
GUA, a chlorine ion is added. AMBER03 (180) force field has been used to describe the 
protein while the osmolytes were described with the GAFF force field (53). All the 
molecular dynamics simulations were performed with the GROMACS molecular 
dynamics package version 4.5.4 (181), (182) 
 
The first step performed was the mechanical unfolding of the β-hairpin in order 
to have the required different initial configurations for umbrella sampling (US). This has 
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been performed via steered molecular dynamics (SMD) keeping the alpha carbon of 
GLY41 fixed and pulling the alpha carbon of GLU56 restraining it with an harmonic 
potential with a force constant of 1000 kJ/(mol nm
2
) to a virtual point moved linearly in 
the z direction with a velocity of 1.0 nm/ns. This is intended to generate structures to use 
in the next US stage where the potential of mean force is calculated. An illustration of 
SMD on the β-hairpin peptide is shown in Figure 17b. 
 
For umbrella sampling, initial configurations are chosen equally spaced along 
the reaction coordinate. From each initial configuration, a dynamic in the NPT ensemble 
has been performed at 300 K and 1 bar. Temperature and pressure were kept constant to 
their reference values using the Nosé–Hoover thermostat (183) and the Parrinello–
Rahman barostat respectively (184). The PMF profile is obtained using the weighted 
histogram analysis method (WHAM) and the error estimation were performed using the 
bayesian bootstrapping (185). The free energy difference ΔG for the mechanical 
unfolding processes is calculated as difference between Gmax, the maximum value of the 
free energy along the unfolding pathway, and Gmin which corresponds to the minimum. 
The standard deviation σ of ΔG is calculated from the sum of variances. 
In order to find the optimal set of simulation parameters to have a converged 
PMF, preliminary tests were performed on the reference system, composed of the β-
hairpin in pure water. An initial set of 20 windows of 5 ns each was used and then both 
the number of windows and the simulation length were increased. It has been found that 
increasing the number of windows from 20 to 37 (keeping unchanged the length of the 
MD associated to each window) caused a large variation on the ΔG of unfolding, while a 
further increase from 37 to 73 windows made no significant changes. Subsequently, 
using 73 windows, the simulation time for each MD was increased up to 15 ns. Non 
converged values were observed until 10 ns, while from 10 to 15 ns a quite robust trend 
toward convergence was observed (Figure 18). This set of parameters (73 windows with 
15 ns long MDs) was then used to simulate all the systems considered, with an analogous 
convergence trend (Figure 18). The value of the force constant Ki of the restraining 
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harmonic potential was set to 1000 kJ/(mol nm
2
). This value should be high enough to 
overcome any energy barrier that could limit the sampling. The chosen value grants a 
good sampling, as it can be inferred from population histograms. The population 
histogram for the reference system is represented in Figure 19. In the histogram, it is 
possible to notice that distributions obtained from contiguous windows well overlap, 
which should guarantee a good sampling along the whole reaction coordinate and thus 
the obtained free energy profiles converges and the error estimation is good (185). This 
is required to be confident in the calculated PMF (133), yet additional criteria have been 
recently discussed by Zhu et al about WHAM (186). 
 
 
Figure 18: Profile of the unfolding free energy as a function of the simulation time. This 
graph shows the effect of the length of each window on the unfolding free energy. This 
corresponds to the set composed of 73 windows. The robust trend of convergence can be 
observed.  
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Figure 19: The histogram obtained for the reference system in umbrella sampling. It 
shows the number of sampled conformations in each window as a function of the 
reaction coordinate. Such graphs are useful to evaluate if the reaction coordinate is fully 
covered by multiple histograms, if all the curves are overlapping properly and to evaluate 
if the force constant used in the biased potential is strong enough.     
 
 
The same protocol has been used to calculate mechanical unfolding ΔG for the 
reference β-hairpin in pure water and for the four systems in osmolytes 2M solution. To 
deal with the huge amount of computation to be done, about 30 years of total CPU time 
on a 8 cores Intel Xeon E5620 CPU @ 2.40 GHz, a BOINC server was installed and the 
work was distributed over a total of 386 volunteers which offer more than one thousand 
computers (187). 
Once all the PMF have been obtained, four ΔΔG were calculated as 
ΔΔG = ΔG − ΔGref, where ΔG is the free energy difference for the system with 
osmolytes and ΔGref is the reference ΔG for the β-hairpin in pure water. A positive 
ΔΔG is expected for osmoprotectants, since osmoprotectants stabilize proteins against 
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denaturation, while a negative ΔΔG is expected for denaturants. To evaluate how much 
these values significantly differ from zero the erf error function is used: 
 
  
 
 
[     (
   
   
)] 
Where σ is the standard deviation of ΔΔG and P is the probability that ΔΔG is greater 
than zero; the probability that ΔΔG is lower than zero is, obviously, the complementary 
to one. 
 
6.3  Free Energy Calculation of Mechanical 
Unfolding Of the Peptide  
The free energy profile of the mechanical unfolding process as a function of the 
distance between the α carbon of the first and of the last amino acid of the peptide, 
corresponding to the reaction coordinate ξ, were analyzed to evaluate similarities and 
differences between the five systems under consideration. The five profiles are shown 
in Figure 20. To make all the curves comparable, the minimum value of the free energy 
was arbitrarily put to zero in each set of data. It is observable that, taken as reference, the 
system with pure water, the two systems containing denaturants, urea and guanidinium 
chloride, always exhibit a lower free energy profile with respect to control, while 
osmoprotectants, glycine betaine and ectoine, have a significant increase in free energy 
in the range between 2.0 and 3.0 nm. This behaviour is in agreement with expectations: 
osmoprotectants protect the peptide making denaturation more difficult, and this result in 
the increase of the unfolding free energy. On the other hand, denaturants exhibit the 
opposite effect decreasing the unfolding free energy, as it is clearly observable in Figure 
20 where curves relative to denaturants are always below the reference. 
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Figure 20: Free energy profile obtained for each analyzed systems as a function of the reaction 
coordinate ξ, i.e. the distance between the α carbon of the first and of the last amino acid of the 
peptide. It is worth noting that osmoprotectants curves show a significant rise in the region 
between 2 and 3 nm, while denaturants curves maintain a lower trend along the whole profile. 
 
Comparing the values at the end of the mechanical denaturation pathway, for the 
osmoprotectants the free energy difference is much higher than the reference, while for 
denaturants it is noticeable lower. Focusing attention on the quantitative ΔΔG and its 
standard deviation, it is interesting to see if osmoprotectants show a significant positive 
ΔΔG, while if for denaturants it is negative. The calculation of the ΔΔG and of its 
probability of being positive or negative was performed as stated in the Materials and 
Methods (section 6.2). Both osmoprotectants show a positive ΔΔG, +7.20 ± 3.50 kJ/mol 
for glycine betaine and +5.24 ± 3.86 kJ/mol for ectoine, with a related probability of 
being positive of 98.0% and 91.3% respectively. Even better results for denaturants: 
guanidinium chloride show a negative ΔΔG of −8.21 ± 3.92 kJ/mol with a probability of 
being negative greater than 98% and urea obtained −14.6 ± 4.88 kJ/mol with a 
probability of 99.9%. 
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To better emphasize the similarities and differences between free energy 
profiles, a numerical differentiation has been performed to get the derivative of the free 
energy with respect to the reaction coordinate. The obtained graphs are shown in Figure 
21. Two prominent peaks can be distinguished: the first one, very sharp, around 0.5 nm, 
the second, with a broader shape, between 2.0 and 3.0 nm. These peaks matches the 
regions along the denaturation pathway where the process involves rapid variations of 
the free energy and can be hypothesized to be in correspondence with regions where 
some significant structural transition along the mechanical unfolding path occur. 
 
 
 
 
Figure 21: Derivative of free energy with respect to the reaction coordinate for the five analyzed 
systems as obtained by numerical differentiation of the PMF. Peaks indicates large variations in 
the free energy profile and focus attention towards particular sections of the reaction coordinate 
interesting for the unfolding process. 
 
6.4  Structural Changes during Mechanical 
Unfolding of the Peptide 
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Although the employed methodology aims at the calculation of free energy 
differences, from this data it is possible to get an insight into the unfolding mechanism of 
the β-hairpin. In Figure 22, some snapshot along the reaction coordinate showing the 
unfolding pathway are depicted. These conformations are obtained from non-equilibrium 
SMD of the reference system. Similar structures are found in the SMD simulations of the 
peptide in osmolyte solutions, thus these snapshot are intended to be indicative of a 
generic mechanical unfolding process along the selected coordinate. In Figure 22a, the 
initial folded structure is shown with the six HBs highlighted in orange and a 
hydrophobic cluster made by residues Trp43, Tyr45 and Phe52. In Figure 22b, is drawn the 
conformation assumed immediately after the first peak in the free energy derivative 
profile, while in Figure 22c and 22d, the conformations assumed before and after the 
second peak are shown respectively. At the end, in the last snapshot, Figure 22e, 
completely steered structure is represented. 
 Analysing the folded structure (Figure 22a), it is observable that it is 
characterised by the presence of six hydrogen bonds (HB) between the backbones of the 
two strands. In addition to these strong, directional, polar interactions, residues Trp43, 
Tyr45 and Phe52 form a little hydrophobic cluster. Looking at the conformations assumed 
by the peptide along the reaction coordinate, in the windows corresponding to the first 
peak, the breaking of the first two HBs is observed (Figure 22b). HBs break occurs in a 
very decisive manner and at 1 nm distance between peptide extremes the two HBs are 
already broken. This is in agreement with the sharp shape of the peak (Figure 21, first 
peak). From 2 to 3 nm instead, in correspondence with the second diffuse peak, the slow 
rupture of the remaining four HBs is observed, rupture concomitant with the breaking-up 
of the non-directional hydrophobic interaction between Trp43, Tyr45and Phe52 (Figure 
22c and 22d). This peak has a broader shape, which is coherent with the interplay 
between directional HBs and non-directional hydrophobic interactions (Figure 21, 
second peak). 
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Figure 22: Some representative snapshots of the unfolding pathway. The value of the reaction 
coordinate in each of the snapshot in figure is: (a) 0.5 nm: the folded stated; (b) 1.3 nm: 
immediately after the first peak in free energy derivative profile plot; (c) 2.1 nm: before the 
second peak; (d) 3.0 nm: after the second peak; (e) 4.0 nm: the completely steered conformation. 
Figure is rendered using VMD software (45). 
 
The differences in the behaviour of osmoprotectants and denaturants with respect 
to the reference in (Figure 21) can be associated to the steps constituting the unfolding 
process, which allows to get some more insight into the qualitative effect of the 
osmolytes on peptide unfolding. At first glance, it is observable that curves referring to 
osmoprotectants in Figure 21 show higher peaks indicating larger energy barriers, 
Chapter 6- Modelling the Effect of Osmolytes on Peptide Mechanical Unfolding  
_______________________________________________________________________ 
 
_______________________________________________________________________ 
86 
 
compared to denaturants curves, which shows lower profiles, sign of reduced energy 
barriers. Focusing on the first peak, both the reference and osmoprotectants show a high 
value of the free energy derivative. This could means the transition associated with the 
first peak, the breaking-up of the first two HBs, is a difficult task to achieve for both the 
system in pure water and with osmoprotectants. The curves referred to denaturants are 
completely different, where the maximum value of the free energy derivative 
corresponding to the first peak is halved, indicating that here denaturants make the 
transition much easier. 
An opposite behaviour is observed in correspondence of the second, broader 
peak. Here the free energy derivative plots in the reference system and in the simulation 
in 2 M denaturants have very similar profiles, showing no significant effects of 
denaturants in the unfolding process. On the other hand the profile for osmoprotectants 
2 M solutions are very different in the region of the second peak. Glycine betaine shows 
two high superimposed peaks, while ectoine shows a large complex peak. For both, the 
area subtended the peak, that is the free energy, is much larger as compared to the 
reference or to denaturants. This could mean in that region of the reaction coordinate, 
where the four innermost HB are break together with the hydrophobic core, the analysed 
osmoprotectants exert their primary action making this transition much more difficult. 
To have a further check about this two-peak behaviour, the non-equilibrium 
force applied during the SMD is studied as a function of the reaction coordinate. A 
representative graph is shown in Figure 23. It is qualitatively observable that how the 
first peak is there immediately between 0.5 and 1.0 nm, and a large and complex second 
peak between 1.7 and 3.0 nm. It goes without saying that the reaction coordinate 
intervals in the non-equilibrium SMD force and in the free energy profile are not exactly 
the same, but it is worth noting how the qualitative behaviour of the non-equilibrium 
SMD force very well fit with the quantitative results obtained from free energy 
calculations. 
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Figure 23: Profile of the force applied to the β-hairpin as a function of the reaction coordinate 
obtained from SMD of the reference system in pure water. The virtual point pulled is the α carbon 
of THR55, pulled at a constant velocity of 10nm/ns. This graph is reported to make a qualitative 
matching with the derivative of the free energy with reference to the reaction coordinate. In both 
graphs, the two-peak behaviour is visible.   
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Conclusions 
 
In this study, it is shown that how it is possible to reproduce the expected trend 
in the mechanical unfolding ΔG of a model system in mixed solutions containing either 
osmoprotectants or denaturants using free energy calculations. The phases of the 
mechanical denaturation process have been observed and the actions of different 
osmolytes capable of increasing or decreasing the unfolding ΔG have been discussed in 
term of free energy derivatives. Umbrella sampling and WHAM here demonstrate their 
potentiality to get powerful insight about protein stability. The results from PMF, and its 
derivative with respect to the reaction coordinate, are in very good agreement with the 
non-equilibrium SMD force and, more interestingly, with structural processes and events 
where the different actions of denaturants and osmoprotectants are related to hydrogen 
bonds breaking and hydrophobic interactions disruption along the reaction pathway.  
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CHAPTER 7 
PROTEIN-PROTEIN 
INTERACTIONS AMONG 
TUBULIN HETERODIMERS: AN 
in-silico STUDY. 
 
 
 
Abstract 
 
Microtubules (MTs) constitute a key component in the cytoskeleton of the living 
organisms and has fundamental role in the process of cell division. Since MTs are crucial 
for cell division, so, they are responsible for the diseases characterized by aberrant or 
unregulated cell duplication, such as cancer. Therefore microtubules act as targets for the 
drugs against such diseases. There are several MT-targeting drugs presently available, 
but because of the problems related to presently available molecules, there is a need for 
the development of new improved MT-targeting drugs. These MT-targeting drugs target 
lateral and longitudinal interactions within MT which encourages us for the detailed 
study about MTs lateral and longitudinal interaction network at the molecular level.  
  
 In this work, we presented a study of the molecular basis of the longitudinal 
interactions as well as lateral interactions between the adjacent tubulin heterodimers 
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using an in silico approach steered molecular dynamics (SMD). Our study has allowed 
us to identify the amino acids and the critical interactions responsible for the binding of 
tubulin heterodimers. The observations that we have obtained are important for the 
design of compounds that target those interactions and acts as inhibitors by interrupting 
the native interactions between α subunit and β subunit of different heterodimer. 
 
7.1  Microtubules  
 
7.1.1 Structure and Dynamics of MT 
 
Microtubules (MTs) are cytoskeletal structures found in all eukaryotic cells. 
They are involved in diverse functions like cell movement, vesicle transportation and 
chromosome segregation during mitosis. Mitotic spindle apparatus is made up of MTs 
(44). MTs are hollow cylindrical structures with an outer diameter of 25 nm. They are 
made up of repeating α-β tubulin heterodimers that binds head to tail to form 
protofilaments, which in turn bind laterally to form sheets and are gradually rolled up 
into a cylindrical structure (Figure 24). Specific number of protofilaments in turn 
associates in parallel to make the MT wall. MTs exist in vivo with varying number of pfs 
(12-16). But under physiological conditions, microtubule with 13 pfs is found most 
commonly (188). To the wall of MT, a variety of Microtubule associated proteins 
(MAPs) and motor proteins binds (189). α and β tubulin subunits are highly homologous 
and composed of 450 amino acids each with high sequence similarity (about 40 %). Each 
subunit is a compact ellipsoid of approximate dimension of 46 x 40 x 65 Å, composed of 
three domains: a N-terminal domain hosting a GTP (guanosine 5‟-triphosphate) / GDP 
(guanosine 5‟-diphosphate) binding site, a central small domain and a C-terminal helical 
domain. Both subunits contain nucleotide binding sites, where one molecule of 
GTP/GDP binds. The final MT structure is organized in a polar manner such that the α-
tubulin subunit is exposed to one end, while the β- tubulin subunit is exposed at the 
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other. The two ends of MT are not equivalent: the β-capped one, known as plus-end, is 
more dynamic, faster growing and faster shrinking than the other, minus-end (190). 
Protofilament elongation, from the so-called minus-end to the plus-end, is closely related 
to the binding and hydrolysis of GTP by tubulin. Both α and β tubulin bind GTP, 
although GTP bound to α tubulin, at the interface between two monomers in the same 
dimer, is nonexchangeable, whereas the nucleotide bound to β tubulin, at the interface 
between two adjoining dimers, is exchangeable. The association between two tubulin 
dimers leads to the hydrolysis of the β tubulin-bound GTP, after a short lag. This β 
tubulin-bound GTP is buried at dimer-dimer interface and becomes nonexchangeable 
too. As a result, the microtubule body is made up of GDP-bound tubulin units, whereas, 
at the growing end, a layer of GTP-bound tubulins (the so-called GTP-cap) is present. A 
polymer made up of just GDP bound is unstable and would lead to the formation of 
curved protofilaments which eventually depolymerize (191). The GTP-cap has a great 
importance in stabilizing a straight protofilament, thus promoting a regular microtubule 
growth.  
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Figure 24: The figure illustrating the structure of microtubule and its polymerization process. 
Microtubule polymerization occurs through α-β tubulin head-to-tail association. Adapted from 
“Microtubule as a target for anticancer drugs” by M.A. Jordan and L. Wilson, 2004, Nat. Rev. 
cancer, 4, p. 254. (192) 
  
 
 
 
 
 
 
 
 
 
Figure 25: The illustration of longitudinal and lateral interactions. Longitudinal interactions run 
along a protofilament and lateral interactions are those between parallel protofilaments. 
 
 
Longitudinal 
interaction 
Lateral interaction 
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Dynamic Instability 
 
Microtubule polymerization is a complex mechanism which involves nucleation 
and elongation processes. MTs are highly dynamic and can switch stochastically 
between growing and shrinking phases. This non-equilibrium behaviour is known as 
Dynamic Instability (Figure 26) (193), (194). Growth and shrinking of MT are 
cooperative processes which involves lateral and longitudinal structural transitions. 
When the GDP-β-tubulin terminus is exposed, as a consequence of the loss of the GTP-
cap, a conformational change is triggered, resulting in rapid depolymerization of the MT, 
this event is called catastrophe (195). On the other hand, the formation of a new layer of 
GTP-bound β-tubulins can restore the protective GTP cap and switch off 
depolymerization, allowing the MT to grow again. This event is known as rescue.  
 
Protofilament polymerization occurs by a delay between the head-to-tail 
association and the GTP hydrolysis. In this way, during the growing phase, a GTP 
molecule can always be present at the plus-end of the protofilaments, thus stabilizing the 
GDP-rich body and allowing the formation of straight microtubules. On the other hand, 
when the GTP cap is lost, protofilaments no longer grow in a straight conformation and 
quickly disassemble. 
 
The polymerization process involves two types of contacts between tubulin 
subunits: longitudinal and lateral. Longitudinal interaction is among the monomers that 
run along the length of the MT whereas lateral interactions occur between parallel pfs 
that complete the MT wall (Figure 25). Longitudinal contacts are much stronger than 
lateral contacts (196). Lateral interactions are either between α-α, β-β or α-β or β-α. This 
depends upon the type of MTs, i.e on the number of protofilaments they are composed 
of.   
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Figure 26: Illustration of dynamic instability in microtubules. MT dynamics is characterized from 
alternative growing and shrinking phases depending on the presence of a GTP-cap at the plus end. 
Adapted from “Tracking the ends: A dynamic protein network controls the fate of microtubule 
tips” by A. Akhmanova and M. O. Steinmetz. 2008, Nat. Rev. Mol. Cell Bio. 9, p. 310. (197)  
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7.1.2  Biological role of Microtubules 
 
MTs are the critical component of a cell which is responsible for maintaining the 
cellular shape, transportation of organelles and vesicles, movement of cytoplasm within 
cells, but especially for the cell division (198), (189). During the process of the cell 
division, mitosis and meiosis, MTs forms „spindle apparatus‟ which refers to the cellular 
structure that segregates chromosomes between daughter cells. It is called as mitotic 
spindle during mitosis and meiotic spindle during meiosis. The spindle apparatus is 
composed of Microtubule organizing center (MTOC), kinetochore, astral microtubules, 
kinetochore microtubules and polar microtubules.  
During the interphase in animal cells (phase of the cell cycle in which cell 
prepares itself for the cell division), usually just one MTOC is present, known as 
centrosome which serves as a central hub for all MTs in the cell (Figure 27). A 
centrosome is comprised of two units, called as centrioles. The two centrioles disengage 
from each other and replicate themselves during S-phase, and then during M-phase, they 
separate to form opposite poles of the cell. Now there are two MTOCs and each MTOC 
would belong to new daughter cell. A new network of microtubules (spindle apparatus) 
can thus grow from the newly generated organelles, extending throughout the cytoplasm. 
During prometaphase and metaphse, MTs are said to fall into three categories:  
 Astral MT: These MTs points outwardly towards the cortex of the cell, in 
order to anchor the whole spindle apparatus. 
 Kinetochore MTs: These MTs attach to the kinetochore of the chromatids.  
 Polar MTs: These MTs are oriented parallel to each other but in opposite 
directions. They are crucial for pushing the spindle apparatus apart during 
mitosis.   
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  Mitosis is divided into five phases based on the physical state of the 
chromosomes and spindle apparatus. These are prophase, prometaphase, metaphase 
anaphase and telophase (Figure 27). (199). During prophase, chromosomes begin to 
undergo condensation process that will continue till metaphase. The spindle apparatus 
begin to form as the two pairs of centrioles move to opposite poles and MTs begin to 
polymerize from the duplicated centrosomes. During prometaphase which is the 
extremely dynamic part of the cell cycle, MTs rapidly assemble and disassemble as they 
grow out of the centrosomes and attaches at chromosome kinetochores. Here, 
chromosomes are pulled in opposite directions by MTs growing out from both poles but 
the sister chromatids do not break apart in this phase. During metaphase, chromosomes 
assumed their most compact form and the centromeres of the cells chromosomes line up 
at the equator. At this phase, cells can be arrested with mitotic poisons such as 
colchicine. A complex checkpoint mechanism of the cell ensures that only those cells 
would enter anaphase which has properly assembled spindles. During anaphase, sister 
chromatids separates from each other. The kinetochore MT shortens and the 
chromosomes started moving towards the opposite poles. During Telophase, 
chromosomes reach the poles and they decondense as the nuclear envelop reforms 
around the two daughter nuclei and; finally by cytokinesis, the cell is divided into two 
separate daughter cells. 
In short, the function of MTs during cell division is the segregation of the 
chromosomes. MTs plus end can grow freely in the cytoplasm reaching a length of 
typically 5-10μm (200) and attaches to the chromosomes. On the other hand, minus end 
of MTs is anchored to the centrosomes. Once a chromosome is bound to one 
microtubule, it then attaches to another one coming from the opposite pole. The tug-of-
war generated by the microtubules coming from the opposite poles, forces the 
chromosomes to align along the cell equatorial plane. At that stage, microtubules 
depolymerization pulls the chromatids to opposite sides of the cell, so allowing the 
anaphase to take place and finally the formation of two daughter cells.   
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Figure 27: Illustration of the phases in the process of mitosis. Adapted from “Mechanisms of 
chromosome behavior during mitosis” by C.E. Walczak et al, 2010, Nat. Rev. Mol. Cell. Bio., 11, 
p. 93.  (201) 
 
7.1.3 Microtubules as a drug-target 
 
As already been discussed, MTs have a fundamental role in mitosis during which 
the duplicated chromosomes of a cell are separated into two identical daughter cells. 
They are responsible for the diseases characterized by aberrant or unregulated cell 
duplication, such as cancer. Therefore, MTs acts as an important target for anticancer 
therapy (202), (200), (203). In depth study of lateral and longitudinal interactions in MT 
is thus essential for the development of MT-targeting molecules. These molecules 
interfere with the dynamics of MT arresting the cell division process in tumor cells (29). 
 
MTs are the targets of a chemically diverse group of antimitotic drugs which binds 
to tubulin at different binding sites and have been used with great success in the 
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treatment of cancer (204), (205). MT-targeting therapeutic agents can be classified into 
two main categories: 
 
1. Microtubule destabilizing agents: These agents inhibits MT polymerization 
causing loss of cellular MTs.  e.g. Vinca alkaloids (vinblastine, vincristine) and 
cochicinoids. 
2. Microtubule stabilizing agents: These agents promotes MT polymerization 
resulting in increased density of cellular MTs.  e.g. taxanes (Paclitaxel) and 
epothilones.  
 
The effects of MT-destabilizing drugs inhibit mitosis and are classified as 
antimitotics (200). Vinca alkaloids and colchicinoids, at high concentration, blocks MT 
dynamics and thus mitosis, leading to cell death by apoptosis. The other class of agents 
which includes paclitaxel acts by stabilizing the MT, so avoiding the transport of the 
chromosomes to the daughter cells.   
 
Current mitotic agents target different binding sites on tubulin and that‟s why they 
have different mechanisms. Their mechanism of action is strongly coupled to the 
mechanism of MT dynamics, especially structural features that affect nucleotide binding, 
GTP hydrolysis and stabilization of longitudinal and lateral protofilament contacts. MT-
targeting drugs target lateral and longitudinal interactions and thus any alterations in 
those interactions suppresses the MT dynamics. Current antimitotic agents are found to 
target three different sites in microtubules structure (Figure 28):  
 The vinca domain: It is located at the interface between two tubulin dimers;  
 The taxol site: It is located on the β-tubulin surface;  
 The colchicine site: It is located at the interface between two monomers.  
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Figure 28: Representation of the binding regions of the microtubule-targeting drugs (vinca 
alkaloids, colchicinoids and taxanes) interfering either longitudinal interactions or lateral 
interactions or both. (a) Vinblastine binds to sites at MT-plus end and suppresses MT dynamics. 
(b) Colchicine form complexes with tubulin dimers and copolymerizes into MT lattice, 
suppressing MT dynamics. (c) Paclitaxel binds to the interior surface of the MT and suppresses 
MT dynamics. Adapted from “Microtubules as a target for anticancer drugs” by M.A. Jordan & L. 
Wilson, 2004, Nat. Rev. Cancer, 4, p. 261. (200) 
 
 
Natural compounds taxanes and epothilones binds to MT at the M loop and 
stabilize lateral contacts between protofilaments (206), (207). Specifically, taxanes like 
paclitaxel binds to taxol site of the tubulin and clinically this drug is widely used against 
ovarian, breast and lung cancer. Vinca alkaloids alters both longitudinal and lateral 
interactions with the preference of suppressing the dynamics at the plus-end. They bind 
to different regions at the large interdimer surface (208). Colchicine site is the target for 
colchicinoids (209), (210). 
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7.2  Study of Longitudinal Interactions Among 
Tubulin Heterodimers 
 
Steered Molecular Dynamics (SMD) has been used to study at atomic level the 
interactions required for the assembly of tubulin heterodimers. To study the longitudinal 
interactions among tubulin heterodimers, we have considered a portion of a microtubule 
protofilament composed of two adjacent tubulin heterodimers. It is done by fixing first 
tubulin heterodimer and pulling the other heterodimer by means of a hypothetical spring 
by using specialized module implemented in Gromacs (182). Then the trajectory was 
analyzed to predict the key interactions responsible for binding longitudinally and to 
describe how these interactions evolve during the course of simulation time as a function 
of the force applied.  
 
 
Figure 29: An illustration representing the SMD applied on a system of tubulin tetramer for the 
study of longitudinal interactions  
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7.2.1 Materials and Methods 
 
The initial structure of tubulin heterodimer for our simulation is retrieved from 
Protein Data Bank (PDB id 1TUB) (211) corresponding to the structure of pig tubulin 
α/β heterodimer which is composed of anti-parallel protofilaments forming a planar 
sheet, resulting in a model specifically suitable for the study of longitudinal interactions. 
Then, the tetrameric structure (composed of two adjacent heterodimers) was built by 
adding to the crystal structure a second dimer with 80 Å translation (on the basis of 
crystallographic information) of the tubulin unit along the protofilament axis which 
corresponds to the x-axis in the PDB file.  
The system is composed of two tubulin heterodimers, i.e a tetramer including 
GTP (Guanosine triphosphate) in each α subunit and GDP (Guanosine diphosphate) in 
each β subunit. Simulations were carried out with Gromacs 4.5.3 package (182), (212) 
and parameters from Amber 03 force field (111) were applied to the system. Explicit 
solvent and periodic boundary conditions were used. Short-range non-bonded 
interactions were cut off at 1.4 nm, with long range electrostatics using the Particle Mesh 
Ewald (PME) algorithm (116), (179). Firstly, topology and coordinate files were 
generated, then a unit cell is defined. Special consideration has been taken while defining 
an unit cell since it must allow enough space in the pulling direction so that it doesn‟t 
interact with the periodic image of the system. A box of size 15 X 15 X 40 nm is used. 
The system was solvated with TIP4P water molecules and neutralized by adding 76 Na
+
 
ions. The system was then energy minimized for 100,000 steps using steepest descent 
algorithm. Then equilibration has been performed for 100 ps with the number of 
particles, system volume and temperature constant (NVT ensemble) in order to 
equilibrate the temperature of the system. Protein and non-protein atoms were coupled to 
separate temperature coupling baths, and temperature was maintained at 310 K using v-
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rescale coupling method (213). V-rescale is a method of temperature coupling using 
velocity rescaling with a stochastic term. This is similar to berendsen thermostat, but the 
stochastic term ensures that a proper canonical ensemble is generated. Subsequently, 
equilibrium of 100 ps is performed with number of particles, system pressure (1 atm) and 
temperature (300 K) constant (NPT ensemble) in order to equilibrate the density of the 
system and a restraint on the positions of Cα atoms. In this case, Berendsen weak 
coupling method (214) is used to maintain pressure isotropically at 1.0 bar. This 
structure was used as starting configuration for pulling simulation (SMD). The pulling 
simulation has been performed for 650 ps and snapshots were saved every 2 ps. For this, 
one dimer is considered as fixed (reference group, dimer A) (Figure 29) and the adjacent 
dimer is being pulled (pull group, dimer B) (Figure 29) with the application of an 
external force along a reaction coordinate z. The dimer B is pulled with a velocity 0.01 
nm/ps using a force constant of 1000 kJ mol
-1
 nm
-2
. To distinguish the dimers, we have 
referred α and β subunit of the first dimer as 1α and 1β and those belonging to second 
dimer as 2α and 2β. Nosé-Hoover thermostat (215), (216) is used to maintain 
temperature, and Parrinello-Rahman barostat (184) is used to isotropically regulate 
pressure. This combination of thermostat and barostat ensures that a true NPT ensemble 
is sampled. During pulling simulation, restraints were removed from the system except 
dimer A. It was used as an immobile reference for the pulling simulation. The main idea 
behind pulling simulation is to capture enough configurations along the reaction 
coordinate to obtain regular spacing of the umbrella sampling windows, in terms of 
center of mass distance between pull group and reference group. Since performing 
umbrella sampling calculations for this system is computationally very expensive, and it 
is very difficult for the present computational power that we have, that is why we had to 
limit the analysis at this point. But, it could be possible in the future with the availability 
of higher computational power. 
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7.2.2  Results and Discussion 
 
Output data of SMD simulation consists of positions along z-axis at 0.001 ps 
intervals, force applied and center of mass (COM) distance between the dimers. By 
pulling the COM of dimer B away from dimer A, force builds up until a breaking point is 
reached, at which time critical interactions are disrupted, allowing dimer B to dissociate 
from dimer A. Figure 30 represents some snapshots of the system which shows how the 
two heterodimers dissociate.  
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Figure 30: Representation of the snapshots of the tubulin tetramer system at different time frames 
during the pulling simulation. Dimer A (reference group) dimer is shown in green and Dimer B 
(pull group) is shown in blue. (a) Starting conformation. (b) At 290 ps. (c) At 324 ps: the time 
corresponding to the maximum force applied. (d) At 350 ps. (e) At 410 ps. 
 
Force applied is plotted as a function of simulation time (Figure 31a). It can be 
clearly observed that initially the force rises till the point of maximum force (2276 
kJ/mol nm) which corresponds to time 324 ps, after that point the force diminishes 
showing the separation of dimers. If we focus on the second plot (Figure 31b) 
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representing the profile of force applied as a function of COM distance, we see that from 
the initial structure (COM distance 8 nm), dissociation is very slow till COM distance of 
about 9 nm, which corresponds to the point of maximum force and after that there is a 
sharp decrease in the force applied. This is because the dimers are dissociated completely 
just within few ps of 324 ps, the time corresponding to the maximum force.  
 
Figure 31: (a) The „applied force‟ profile with respect to the time during the dissociation of the 
two heterodimers. The point of maximum force (2276 kJ/mol nm) is represented by blue line 
which is at 324ps (b) Force-extension profile: the profile of the force applied with respect to the 
center of mass distance between the two dimers during the dissociation process. 
 
A deeper insight into the network of interactions between the residues at the 
interface that contribute to microtubule stability can be obtained by analysis of the 
simulation trajectory relating it with the force applied. Throughout this chapter, all the 
amino acids on α-tubulin subunit will be referred by their position and those on β-tubulin 
subunit will be referred with a „’‟ over the residue number. In this study of dissociation 
of two heterodimers, the point of maximum force corresponds to the instant just before 
the breaking of few critical interactions between the two heterodimers. One of them is 
the hydrogen bond between Val 353 of α subunit of first heterodimer and Asp 177‟ of β 
subunit of second heterodimer breaks. This hydrogen bond is between the backbone 
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Nitrogen of Val 353 and backbone Oxygen of Asp 177‟. Figure 32b represents the 
dissociation of this interaction just after the point of maximum force. To support our 
findings, we have compared them with the observations from CAS studies previously 
performed by our group (30). Peraccini et al have stated the presence of the above 
mentioned interaction. Moreover, In the same study, CAS study of the interface residues 
of the tubulin tetramer has predicted Val 353 as a warm spot (ΔΔG = 3.33 kcal/mol) and 
Asp 177‟ as a good hot spot with high ΔΔG = 15.23 kcal/mol, implying both of the 
above mentioned amino acids are important for the longitudinal interaction among 
tubulin heterodimers. Also, Asp 177‟ belongs to the T5 loop (according to the tubulin 
secondary structure classification proposed by Lowe et al (44), Val 353 is a part of S9 
strand; and according to the MT models (190), T5 loop and S9 strand were proposed to 
interact with each other on the geometrical basis.  
On the basis of thorough analysis of the various interdimer interactions, we have 
found that after reaching the maximum force at 324 ps (Figure 31a), many interactions 
were disrupted within only 14 ps. This observation highlight the importance of those 
interactions in stabilizing the microtubule.  
The interactions that we have observed are discussed as follows. Thr 349 of 1α 
subunit interact with Val 175‟ of 2β subunit via a hydrogen bond (Hbond). This is in 
agreement with the observations from the previous studies by our group by Pieraccini et 
al. Moreover, according to CAS study both of these residues were predicted to be hot-
spot and warm spot with ΔΔG of 4.60 kcal/mol and 2.47 kcal/mol respectively (Figure 
33). Backbone oxygen of Gln 256 on 1α subunit interact with sidechain nitrogen of Trp 
397‟ on 2β subunit through a Hbond. Another Hbond is observed between sidechain 
oxygen of Asn 258 and backbone nitrogen of Val 179‟. Sidechain oxygen of Glu 254 
interacts via Hbond with sidechain nitrogen of Asn 99‟. We have also observed some 
hydrophobic key interactions which are responsible for the stability of microtubules. Pro 
325 interact with Tyr 222‟ and Tyr 208‟ via hydrophobic interactions. This is in 
agreement with the previous study by our group (217). ∆∆G values obtained from CAS 
studies supports these observations. The tetramer is stabilized by hydrogen-bonding and 
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hydrophobic interactions. The use of COM pulling allows monitoring of the evolution of 
these interactions over time as dimer B is pulled away from dimer A. This gives 
qualitative assessment of the specific interactions between the two heterodimers which 
stabilizes the microtubule longitudinally. 
 
 
Figure 32: (a) Initial configuration of the tetramer showing Hydrogen bond between Val353 of α 
subunit of dimer A and Asp 177‟ of β subunit of dimer B. (b) Snapshot showing the breaking of 
Hydrogen bond between Val353 and Asp177‟ just after the point of maximum force (at 324 ps).  
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Figure 33: ΔΔG values obtained from CAS study for the residues located at the tubulin-tubulin 
longitudinal interface. The residues with a prime symbol („) belongs to β-tubulin subunit (30) 
 
An in-silico analysis of the protein-protein interface was carried out with Steered 
Molecular Dynamics studies. We have used a harmonic potential in order to make 
qualitative observations about the dissociation pathway corresponding to the separation 
of tubulin heterodimers. The harmonic potential allows the force to vary according to the 
nature of the interactions of dimer A with dimer B. That is, the force will build up until 
certain critical interactions are broken. We were able to monitor how the interactions 
evolve with respect to the time during the dissociation process. This study could be 
valuable in better understanding of the longitudinal interactions along the protofilament 
that stabilize the microtubule.  
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7.3  Study of Lateral Interactions among Tubulin 
Heterodimers 
MTs possess lateral flexibility to enable bending with high curvature and it is 
based on interprotofilament interaction or lateral interaction; and is crucial for 
maintaining cellular shape, cellular transport and cell division. We have studied the 
interaction network responsible for stabilizing the MT laterally using an in-silico 
approach: SMD. To study lateral interactions among MT protofilaments, we have 
considered a portion of MT comprising two nearby parallel protofilaments. Two tubulin 
heterodimers belonging to different protofilament were chosen for the study (Figure 34). 
This study helps in having a detailed view of the interactions responsible for MT 
stabilization and also in exploring time evolution of the crucial interactions. 
 
 
Figure 34: (a) Structure of microtubule showing the two tubulin heterodimers (in box) considered 
for the study. (b) An illustration representing the SMD applied on a system of tubulin tetramer for 
the study of lateral interactions in MT. 
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7.3.1 Materials and methods 
 
The initial structure of tubulin heterodimer for our simulation is retrieved from 
Protein Data Bank (PDB id 1TUB) (211) corresponding to the structure of pig tubulin 
α/β heterodimer. Then, the system to be studied (composed of two heterodimers) was 
built by adding to the crystal structure a second dimer (on the basis of crystallographic 
information) from the adjacent protofilament.  
The system is composed of two tubulin heterodimers from two adjacent 
protofilaments, which includes GTP (Guanosine triphosphate) in each α subunit and 
GDP (Guanosine diphosphate) in each β subunit. Simulations were carried out with 
Gromacs 4.5.3 package and parameters from Amber 03 force field were applied to the 
system. All the parameters used are similar to that of the longitudinal interaction study. 
Special consideration has been taken while defining a unit cell since it must allow 
enough space in the pulling direction so that it doesn‟t interact with the periodic image of 
the system. A box of size 16 X 35 X 16 nm is used. The system was solvated with TIP4P 
water molecules and neutralized. Energy minimization and equilibration has been 
performed. The structure obtained after equilibration was used as starting configuration 
for pulling simulation (SMD). The pulling simulation has been performed for 650 ps and 
snapshots were saved every 2 ps. For this, one dimer is considered as fixed (reference 
group, dimer A) (Figure 34b) and the other dimer is being pulled (pull group, dimer B) 
(Figure 34b) with the application of an external force along a reaction coordinate y. The 
dimer B is pulled with a velocity 0.01 nm/ps using a force constant of 1000 kJ mol
-1
 nm
-
2
. We have referred α and β subunit of the first dimer as 1α and 1β and those of second 
dimer as 2α and 2β. During pulling simulation, restraints were not applied on the system 
except dimer A which is considered as immobile reference for the pulling simulation.  
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7.3.2 Results and Discussion 
 
By pulling the COM of dimer B away from dimer A, force builds up until a 
breaking point is reached, at which time critical interactions are disrupted, allowing 
dimer B to dissociate from dimer A. Figure 35 represents some snapshots of the system 
which shows how the two dimers have separated.  
 
Figure 35: Representation of the snapshots of the tubulin tetramer system at different time frames 
during the pulling simulation. Dimer A (reference group) is shown in green and Dimer B (pull 
group) is shown in blue. (a) Initial structure. (b) Snapshot taken before the point of maximum 
force, at 132 ps. (c) Snapshot at the time of maximum force, 220 ps. (d) Snapshot taken after the 
point of maximum force, 310 ps. 
 
Forces applied is plotted as a function of simulation time (Figure 36a). It can be 
clearly observed that initially the force rises till the point of maximum force (1535 
kJ/mol nm) which corresponds to time 220 ps, after which the force diminishes showing 
the separation of dimers. If we focus on the second plot (Figure 36b) representing the 
profile of force applied as a function of COM distance, we see that from the initial 
structure (COM distance 5.2 nm), dissociation is very slow till COM distance of about 
5.8 nm, which corresponds to the point of maximum force and after that there is a sharp 
decrease in the force applied. This is because the dimers are dissociated completely just 
within few ps of 220 ps, the time corresponding to the maximum force. 
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Figure 36: (a) The „applied force‟ profile with respect to the time during the lateral dissociation 
of the two heterodimers. The point of maximum force (1535 kJ/mol nm) is represented by red line 
which is at 220ps (b) Force-extension profile: the profile of the force applied with respect to the 
center of mass distance between the two dimers during the lateral dissociation process. 
 
A deeper insight into the network of interactions between the residues at the 
interface that contribute to microtubule stability can be obtained by analysis of the 
simulation trajectory in relation with the force-time and force-com profile obtained. In 
this study of dissociation of two heterodimers, the point of maximum force corresponds 
to the instant just before the breaking of few critical interactions between the two 
heterodimers. One of the important interaction among them is the hydrogen bond 
between Arg 86‟ of 1β subunit of first heterodimer and Gln 279‟ of 2β subunit of second 
heterodimer breaks. This hydrogen bond is between the sidechain Nitrogen of Arg 86‟ of 
1β and sidechain Oxygen of Gln 279‟ of 2β. Figure 37b represents the dissociation of 
this interaction just after the point of maximum force. In another study about the lateral 
interactions between protofilaments, our group has predicted the residues that are crucial 
for lateral binding of tubulin subunits using CAS. In that study, CAS analysis of the 
interface residues of the same system has predicted Arg 86‟ as a hot spot (ΔΔG = 5.75 
kcal/mol) and Gln 279‟ as a warm spot with ΔΔG = 2.46 kcal/mol, implying both of the 
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above mentioned amino acids are important for the lateral interaction among tubulin 
heterodimers. (Figure 38) 
 
 
Figure 37: (a) Initial configuration showing Hydrogen bond between Arg 86‟ of 1β and Gln 279‟ 
of 2β. (b) Snapshot taken just after the point of maximum force showing which corresponds to the 
breaking of the Hydrogen bond between Arg 86‟ of 1β and Gln 279‟ of 2β.   
 
On the basis of thorough analysis of the various interdimer lateral interactions, 
we have found other interactions that play a role in stabilization of the MT. Backbone 
oxygen of Thr 56 of 1α subunit interact with backbone nitrogen of Glu 284 of 2α subunit 
via a Hbond. According to CAS study Thr 56 was predicted to be a warm-spot with ΔΔG 
of 2.25 kcal/mol (Figure 38). Another Hbond is observed between sidechain nitrogen of 
Gln 85 on 1α and backbone oxygen of Glu 279 on 2α. Sidechain oxygen of Glu 125‟ on 
1β interacts via Hbond with sidechain nitrogen of Lys 336‟ on 2β. The use of COM 
pulling allows monitoring of the evolution of these interactions over time as dimer B is 
pulled away from dimer A. This gives qualitative assessment of the specific interactions 
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between the two heterodimers which sare responsible for the stability and dynamics of 
the microtubule. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure: ΔΔG values obtained from CAS study performed by our research group, for the residues 
located at the tubulin-tubulin lateral interface. The residues with a prime symbol („) belongs to β-
tubulin subunit 
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Conclusions & Future perspectives 
This work underscores how Steered Molecular Dynamics studies can provide 
detailed information in terms of key interactions involved in protein-protein interface of 
tubulin heterodimers that are important for the stability of microtubules. Thus, we can 
propose that the compounds designed to interfere with the observed interactions between 
the two heterodimers, may act as viable therapeutic candidates to destabilize or inhibit 
the tubulin-tubulin interaction. In silico analysis of protein- protein interface can in 
perspective be useful in development of drug like compounds targeting protein-protein 
interactions, i.e. in targeted drug design.  
Because of the limitation of the computational power, further analysis of the 
longitudinal and lateral interface could not be performed. Although, in future with 
enhanced computational power, it would be possible to calculate the free energy of 
binding of dimers by implementation of Umbrella sampling method.      
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